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INTRODUCTION 
Differentiating ischemic from nonischemic cardiomyopathy poses a particular 
problem, but this is important prognostically and therapeutically. Patients with  
ischemic cardiomyopathy have worse prognosis than the patients with idiopathic 
dilated cardiomyopathy. Joseph et al, in 1983 have demonstrated that in patients with 
severe chronic left ventricular failure, mortality rate in patients with coronary artery 
was 46% and 69% at 1 and 2 years, respectively compared with  23% and 48% at 1 
and 2 years in those with idiopathic dilated cardiomyopathy 1. In 1997, Bradley and 
colleagues also have shown ischemic etiology is a significant independent predictor of 
mortality in patients with cardiomyopahy 2.  
Therapeutically also it is important to distinguish between ischemic and 
nonischemic cardiomyopathy because the diagnosis influences the management. 
Antiplatelets and lipid lowering therapy are important in management  of  patients 
with cardiomyopathy of  ischemic etiology. Revascularisation  in patients with low 
ejection fraction and significant coronary artery  disease is strongly associated with 
improved survival 3-5 and should be considered in all patients with ischemic 
cardiomyopathy and proven hibernation. Moreover ischemic cardiomyopathy may not 
respond to medical therapy as favorably as patients with nonischemic 
cardiomyopathy. 
 Differentiating ischemic from nonischemic cardiomyopathy clinically is not 
always easy. Although ischemic cardiomyopthy is generally a late consequence of  
clinically established coronary artery disease, sometimes the clinical course is really 
occult and indistinguishable from idiopathic cardiomyopathy. An ischemic cause is 
probable in patients with history of   definite or documented prior myocardial 
infarction or left ventricular aneurysm in echocardiogram 6,7. However, some patients 
with ischemic  cardiomyopathy  have neither history nor electrocardiographic 
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evidence of  myocardial infarction 8,never complaint of chest pain 9 and  shows  
diffuse  rather  than  regional  hypocontractility 6,10. Conversely many  patients  with  
idiopathic  dilated cardiomyopathy  report  frequent  episodes  of  chestpain 11 and  
have  electrocardiographic  evidence  of  myocardial  infarction 12.       
 Appropriate  differentiation  of  these  two  cardiomyopathy  is  achieved  by  
coronary  angiography  since  it  remains  the  gold  standard  test  to  identify  
coronary  artery  disease, but  coronary  angiogram  is an  invasive  method  with  its  
attendant  risks so  a  noninvasive  method  would  be  preferable  which  may  
decrease  the  unnecessary  risk, cost  and  inconvenience  associated  with  cardiac  
catheterization. Unfortunately  most  of  the  currently  used  noninvasive  methods  to  
distinguish  the  etiology of  left  ventricular  dysfunction  have  been  of   limited  
value 13 and  many  non-invasive  techniques  have  been  tested  with  variable 
accuracy 14,15,16,17,18,19. There  are  some   limitations  in  interpretation  and  availability  
of  these  tests  while  inconsistent  findings  have  been  reported. The  relatively  low  
specificity  and  predictive  value  of  these  tests  which  are further  reduced  with  
more  pronounced  left  ventricular  dysfunction  often  preclude  definitive  clinical  
decisions  in  individual  cases.       
 Ischemic  cardiomyopthy  may  be  suspected  on  the  basis  of  clinical  and  
electrocardiographic data. However, the  sensitivity  and  specificity  of  these  data  
are  often  inadequate  for  individual  patient  management  decisions 20,21,22,23,24  and  
further  confounded  by  the  frequent  presence  of  a  nondiagnostic  
electrocardiography  with  conduction  abnormalities 24 and  high  prevalence  of  
asymptomatic  myocardial  infarction 8.Exercise  stress testing  is  the  standard  
noninvasive  technique  used  for  detection  of  coronary  artery  disease  in  patients  
without  significant  left  ventricular  dysfunction  or  dilated  cardiomyopathy, but  it  
is  not  being  used  for  diagnostic  purpose  in  patients  with  dilated  heart  and  left  
ventricular  dysfunction  because  of  their  reduced  ability  patients to  perform  
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dynamic  stress. Additionally  frequent  presence of electrocardiographic  conduction  
abnormalities in these  group  of  patients  at  rest  impairs  interpretation  of   stress  
electrocardiography.  
 The  detection  of  regional  wall  motion  abnormalities  at  rest  by  
echocardiography  or  ventriculography (contrast or radionuclide)  is  often  thought  
to  be  a  reliable  indicator  of  presence  of  significant  coronary  artery  disease  
obstruction  and  prior  myocardial  infarction 25-27, but  Robert  et  al 6  demonstrated  
that  resting  regional  wall  motion  abnormalities  detect  significant  coronary  artery  
disease  with  high  specificity  in  patients  with  normal  sized  ventricle  but  has  
low  specificity  in  patients  with  dilated  ventricles. Moreover  regional  wall  
motion  abnormalities at  rest  have  been  demonstrated  in  as  many  as  two  thirds  
of  patients  with  nonischemic  cardiomyopathy  whereas  patients  with  ischemic  
cardiomyopathy  might  have  uniform  hypokinesia 6. So   resting  regional  wall  
motion  abnormalities  do  not  reliably  distinguish  ischemic  from  nonischemic  
cardiomyopathy. 
 Dobutamine  stress  echocardiography  is  an accurate  noninvasive  
technique  for  evaluating  coronary  artery  disease  in  nondilated  heart  with  
sensitivity  and specificities  in  the  range  of  80-85% 26, but  only  limited  data  
available  about  the  role  of  dobutamine  stress echocardiography  in detection  of  
coronary artery  disease  in  dilated  cardiomyopathy  which  had  been  done  in  
small  number  of  patients. Moreover  adequate  training  is  required  to  obtain  these  
impressive  results 29.Also  the  lack  of  uniform  diagnostic  criteria  is  a  significant  
limitation  in  the  agreement  of   even  expert  readers, especially  in  situations  of  
poor  imaging  quality   and  subtle  wall  motion  abnormalities. The  fundamental  
problem  underlying  both  of  these  limitations  is  the  subjective  nature  of  stress  
echocardiography. Also  presence  of  left  bundle  branch   block  which  is  being 
 4
common  in  dilated  cardiomyopathy  patients  further  impair  the  wall  motion  
analysis  during  stress  echocardiography. 
 Several  other  noninvasive  techniques  such  as  right  ventricular  function, 
coronary  echocardiography, resting  thallium-201  myocardial  perfusion  scanning, 
positron  emission  tomography(PET),  coronary  calcium score  using  electron  beam  
computed  tomography(EBCT),  carotid  scanning  for  measuring  carotid  
atherosclerosis  have been  used  to  distinguish  these  two  forms  of  
cardiomyopathy,  but  distinction  has  been  limited  by  controversial  findings. 
 Right ventricular function — The right ventricular ejection fraction (RVEF) 
has been proposed as a means of distinguishing between ischemic and nonischemic 
cardiomyopathies. Ischemia and infarction usually spare the right ventricle; as a 
result, patients with an ischemic cardiomyopathy should have a relatively normal 
RVEF. In contrast, a nonischemic cardiomyopathy is a global process that should 
involve the right ventricle and should be associated with a reduced RVEF. 
Once again, this theoretical distinction has limited clinical utility 43,44. In one series of 
23 patients with idiopathic cardiomyopathy and 36 patients with ischemic 
cardiomyopathy, the mean RVEF was, as expected, lower in patients with a 
nonischemic cardiomyopathy (31% versus 45% for those with an ischemic 
cardiomyopathy)43. However, there was considerable overlap between the two groups: 
22 percent of patients with a nonischemic cardiomyopathy had a normal RVEF, while 
34 percent of patients with an ischemic cardiomyopathy had a reduced RVEF43. In 
another study of 76 patients with proven nonischemic cardiomyopathy, 54 percent had 
normal RVEF in the presence of reduced LVEF 44. 
 Transthoracic  coronary  echocardiography  was  used  in  one  study  to  
distinguish  ischemic  from  nonischemic  cardiomyopathy  on  the  basis  of  
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visualization  of  coronary  arteries, but  it  is  not  possible  to  visualize  coronary  
arteries  in  all  patients by  transthoracic  echocardiogram, and  also  only  proximal  
coronaries  can  be  visualized. Thallium  scintigraphy  has  been  used  in  
differentiation  of   ischemic  from  nonischemic  cardiomyopathy, but  it  gives  false-
positive  anteroseptal  and  septal  perfusion  defects  in  patients  with  left  bundle  
branch  block 30.Positron   emission  tomography(PET)  has  also  been  shown   to  
been  useful  to  identify  ischemic  etiology  in  patients  with  dilated  
cardiomyopathy, but  is  limited  by  its  availability  and  expense.  
A  number  of  authors  have  proposed  that  the  development  of  a  user-
friendly  quantitative  approach  should  overcome  the  limitations  of  the  subjective  
evaluation  of  dobutamine  stress echocardiography  images 31,32 and  other  currently  
used  techniques. Several  investigators  have  shown  Tissue Doppler 
Imaging(TDI), a  novel  echocardiographic  method  that  measures  the  long  axis  
function  of  the  ventricles quantitatively, to  be  a   sensitive  alternative  to  the  
present  echocardiographic   and  scintigraphic  imaging  techniques   to  evaluate  
stress  tests 33,34.Quantification  of  myocardial  function  by  Pulsed  Doppler  
myocardial  imaging  during  dobutamine  stress  have  also  been  demonstrated  to  
be  a  feasible,  accurate, and  reproducible  technique 34. 
 Left ventricular  fibres  are  predominantly  arranged  longitudinally  or  
obliquely in  the  subendocardium  and  subepicardium  and  circumferentially  in  the  
intermediate layers. During  early  systole, the  longitudinal  and  oblique  fibres  
begin  to  contract first  causing  the  long-axis  to  shorten  and  the  left  ventricular  
cavity  to  become more  spherical. After  a  mean  delay  of  25 ms  the  
circumferential  fibres  also  begin to  contract, and  throughout   the rest  of  systole  
both  circumferential  and  longitudinal axes  contract  synchronously 33. This  normal  
pattern  is  disrupted  early  in  coronary artery  disease  as  subendocardial  
longitudinal  fibres  are  more  sensitive  to  ischemia  34 than  circumferential  fibres. 
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Therefore  abnormalities  of  long  axis  function  may  be  of  practical  use  as  
indicators  of  ischemia  during  stress  testing 35. Furthermore  stress  induced  
changes  in  long  axis  function  can  be  measured objectively 36,37. 
By  studying  left  ventricular  long  axis  function  by  simple  M-mode  
echocardiography, Mishra  et  al  reported  that  the  normal  increase  in  systolic  
amplitude  of  mitral  annulus  occurring  with  dobutamine  administration  is  
attenuated  in  patients  with  coronary  artery  disease  and  normal  left  ventricular  
dimension 38. Simonson and  Schiller 39  showed  that  a  reduction  in  long  axis  
function, called descent  of  the  base  in  their  study, correlated  well  with  impaired  
left  ventricular ejection  fraction  in  a  large  group  of  patients  including  those  
with  coronary  artery disease. Gibson’s group 22 confirmed  that, in  patients  with  
ischaemic  disease, long-axis  shortening  was  delayed  to  85 ms  after  the  Q  wave  
from  a  normal  mean  of 55 ms, along  with a  reduction  in  the  amplitude  of  long  
axis  shortening. Similar  results  were  found  by  Henein et al.40  who  further  
showed  that  these abnormalities  resolved  after  successful  angioplasty. This  
suggested  that  longaxis function  might  be  useful  for  the  detection  of  ischaemia. 
Alam  and  associates 35 assessed  long  axis  shortening  before  and  after  bicycle  
exercise  and  found  that  there  was  a blunted  increase  of  long  axis  shortening  in  
patients  with  coronary  artery  disease. They  used   an  upper  limit  of  normal  of  3 
mm  based  on  inter-observer  variability. This  gave  a  sensitivity  of  76%  for  the  
detection  of  angiographically  significant coronary  artery  disease  and  of  88%  for  
the  detection  of  reversible  ischaemia  on thallium  stress  imaging. However, the 
sensitivity  was  only  50%  for  single  vessel disease. Based  on  the  above  
observations  Duncan  and  co-workers  used  left  ventricular  long  axis  function  
during  dobutamine  stress  to  differentiate  ischemic  from  nonischemic  
cardiomyopathy  and  compared  with  wall  motion  score  index  and  observed  
quantified  stress  long  axis  function  identifies  coronary  artery  in  dilated  
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cardiomyopathy  with  greater  sensitivity  and  specificity  than  standard  wall  
motion  score  index,  particularly  in  the  presence  of  left  bundle  branch  block. 
But  his  study  group  consist  of  unselected  group  of  patients  with  dilated  
cardiomyopathy  which  included  patients  with  prior  history  of  myocardial  
infarction  where  the  etiology  of  cardiomyopathy  is  clinically  obvious  and  no  
further investigations  are  required  for diagnosis  itself.   
In  this  context  we  aimed  to  differentiate  the  Ischemic  from  Nonischemic  
cardiomyopathy  by  using  tissue  doppler  parameters  during  dobutamine  stress .   
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REVIEW   OF   LITERATURE 
DEFINITION OF CARDIOMYOPATHY  
WHO defined Cardiomyopathies as diseases of the myocardium associated 
with cardiac(systolic and/or diastolic)  dysfunction 41. Cardiomyopathies constitute a 
group of  disorders in which the dominant feature is direct involvement of the heart 
muscle itself. By strict definition, they are a primary myocardial disorder and not 
related to the effects of conditions such as pre-existing valve disease, hypertension, 
and coronary artery disease. From a practical standpoint, severe dysfunction due to 
diffuse coronary artery disease and the effects of coronary ischemia is often 
considered a form of  cardiomyopathy (Ischemic cardiomyopathy). 
CLASSIFICATION  
The World Health Organisation /International Society and Federation of 
Cardiology Task Force recommended that cardiomyopathies be classified by the 
dominant pathophysiological mechanism or  etiologic/pathogenic  factor 41 
 By mechanism    By Disorder 
 Dilated cardiomyopthy   Ischemic cardiomyopthy 
 Hypertrophic cardiomyopthy   Valvular cardiomyopathy 
 Restrictive cardiomyopthy   Hypertensive cardiomyopathy 
 Arrhythmogenic right ventricular  Inflammatory cardiomyopthy 
  cardiomyopthy   Metabolic cardiomyopthy 
 Unclassified cardiomyopthies   General system disease 
       Muscular dystrophy 
       Neuromuscular disorders 
       Sensitive and toxic reaction 
       Peripartum cardiomyopathy 
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DILATED  CARDIOMYOPATHY                 
Dilated cardiomyopathy is characterized by dilatation and impaired 
contraction of the left  or both ventricles. Both  end-diastolic  and  end-systolic  
dimensions  and  volumes  are   increased, and  variables  of  systolic  
function(ejection  fraction,  fractional  shortening,  systolic  longitudinal  motion  of  
mitral  annulus,  stroke  volume,  and  cardiac  output) are  uniformly  decreased. With  
gradual  dilatation  more  along  the  short  axis  of  the  left  ventricle, the  LV  cavity  
becomes  more  spherical,  with  a  sphericity  index(long-axis  dimension/short  axis  
dimension) nearing  the  value  of  1 (normal >1.5). Wall  thickness  varies  but  
typically  is  within  normal  limits; however,  the  LV  mass  is  uniformly  increased. 
Secondary   features  include  dilated  mitral  annulus  and  incomplete  coaptation   of  
the  mitral  valve  leaflets  responsible  for  the  associated  functional  mitral  
regurgitation,  evidence  of  low  cardiac  output,  enlarged  atrial  cavities,  right  
ventricular  enlargement,  and  apical  mural  thrombus. Intraventricular  conduction  
delay (left  or  right  bundle  branch  block)  is  common  and  contributes  further  to  
cardiac  dysfunction   by  causing  intraventricular  mechanical  dyssynchrony. 
It may be idiopathic, familial/genetic, viral and/or immune, alcoholic/toxic, or 
associated with recognized cardiovascular disease in which the degree of myocardial 
dysfunction is not explained by the abnormal loading conditions or the extent of 
ischemic damage. Histology is nonspecific. Presentation is usually with heart failure, 
which is often progressive. Arrhythmias, thromboembolism, and sudden death are 
common and may occur at any stage. 
ISCHEMIC CARDIOMYOPATHY 
In  1970,  Burch  and  colleagues  first  used  the  term   ischemic  
cardiomyopathy  to  describe  the  condition  in  which  coronary  artery  disease  
results  in  severe  myocardial  dysfunction  with  clinical  manifestation  often  
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indistinguishable  from  those  of  primary  dilated  cardiomyopathy. Symptoms  of   
heart  failure  caused  by  ischemic  myocardial  dysfunction  and  hibernation,  
diffuse  fibrosis,  or  multiple  infarctions,  alone  or  in combination  may  dominate  
the  picture  of  coronary  artery  disease. In  some  patients  with  chronic  coronary  
artery  disease,  angina  may  be  the  principal  clinical  manifestation  at  one  time,  
but  later  this  symptom  diminishes  or  even  disappears  as  heart  failure  become  
more  prominent. Other  patients  with  ischemic  cardiomyopathy  have  no  history  
of  angina  or  myocardial  infarctions(type I silent  ischemia),  and  it  is  in  this  
subgroup  that  ischemic  cardiomyopathy  is  most  often  confused  with  dilated  
cardiomyopathy 42.  
Ischemic  cardiomyopathy  is  the  term  used  by  some  to  describe  the 
condition  in   which  coronary  artery  disease  causes  multiple  infarctions, diffuse  
fibrosis,  or  severe  ischemia  that  leads  to  left  ventricular  dilatation  with  
congestive  heart  failure   and  it  may  or  may  not  be  associated  with  angina  
pectoris. They consider  ischemic  dilated  cardiomyopathy  is  usually  a  late  result  
of  clinically  overt  coronary  artery  disease.43 
WHO  designation   of  ischemic  cardiomyopathy  as  a  specific 
cardiomyopathy  “with  impaired  contractile  performance  not  explained  by  extent  
of  coronary  artery  disease  or  ischemic  damage”  has  led  to  confusion. If   
ischemia  is  thought  not  be  the  cause  for  impairment,  perhaps  the  adjective  
should  be  replaced  by  one  describing  the  perceived  cause,  or  by  idiopathic.  
Most  clinicians  use  ischemic  cardiomyopathy  to  describe  dilatation  and  
dysfunction,   which  they  believe  is  caused  by  an   ischemic  insult.             
The  frequency  with  which  the  diagnosis  of  ischemic  cardiomyopathy  is 
missed  should  not  be  underestimated. In  one  study  of  112  cardiac transplant 
recipients, severe  coronary  disease  was  found  in  all  patients  with  a pretransplant  
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diagnosis  of  ischemic  cardiomyopathy (57 percent  of  the total population); CAD  
was  also  present  in  9  of  38(24%)  patients  with  a  pretransplant  diagnosis of  
idiopathic  dilated  cardiomyopathy  and  in  three  of  four  with  presumptive 
alcoholic cardiomyopathy. 
Enlarged and globally hypokinetic left ventricles may at times challenge 
physicians concerning the  etiology of this finding, since the underlying cause cannot 
always be determined, even after detailed history and skilled clinical evaluation, 
including echocardiography. Dilated cardiomyopathy, either idiopathic or secondary 
to specific disorders but without coronary stenoses 41, and ischaemic cardiomyopathy 
due to severe coronary artery disease have been used to describe left or biventricular 
dilatation in addition to impaired contraction. It may be difficult to distinguish 
between them clinically. An ischemic cause is probable in patients with a history of 
myocardial infarction (MI) or left ventricular (LV) aneurysm3,4 .However, some 
patients with ischemic DCM have neither history nor electrocardiographic (ECG) 
evidence of MI5 never complain of chest pain 6,and show diffuse, rather than regional, 
LV hypocontractility3, 7. Conversely, many patients with idiopathic DCM report 
frequent episodes of chest pain s and have ECG evidence of MI 9.  Ischemic 
cardiomyopathy is usually a late result of clinically overt coronary artery disease 45. 
However, sometimes the clinical course of the disease is really occult and, 
indistinguishable from dilated cardiomyopathy43,45,46. Differentiating between this 
latter ‘silent’ ischemic and non-ischemic cardiomyopathy is imperative for both 
therapeutic and prognostic reasons 47,1,48. Although ischemic cardiomyopathy bears a 
worse prognosis than non-ischemic cardiomyopathy 1,48,49, patients with proven 
hibernation may show an improved outcome after myocardial revascularization 50. 
Appropriate differentiation is achieved by coronary angiography, since it still remains 
the gold standard. Many non-invasive techniques have been tested in this distinction 
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with variable accuracy 15-19, 51. However, there are some limitations in interpretation 
and availability of these tests while inconsistent findings have been reported. 
 On reviewing the  old  literatures   the  following  parameters  and  
noninvasive  techniques  were  used  to  differentiate  ischemic  from  nonischemic  
dilated  cardiomyopathy 
 1. Clinical  and  electrocardiographic  data 
 2. Regional  wall  motion  abnormalities  detected  at  rest 
 3. Wall  motion  analysis  by  Dobutamine  stress  echocardiography 
 4. Right  ventricular  function 
 5. Coronary  echocardiography 
 6. Radionuclide  ventriculography 
 7. Electron  beam  computed  tomography 
 8. Thallium-Dipyridamole  scintigraphy   
 9. Magnetic  Resonance  Imaging (MRI) 
 10. Carotid  ultrasound 
 11. Valvular  and  thoracic  aortic  calcification  
 12. Tissue  doppler 
CLINICAL  AND  ELECTROCARDIOGRAPHIC  DATA 
Patients  with  severe  LV  dysfunction  due  to  coronary  artery  disease  or  
nonischemic  cardiomyopathy  may  present  with   identical  symptoms 52. Chest  
pain  is  considerd  to  one  of  the  cardinal  symptom  of  coronary  artery  disease. 
However,  some  patients   with  ischemic  DCM  never  complaint  of  chest   pain9. 
Conversely  many  patients  with  idiopathic  DCM  report  frequent  episodes  of  
chest   pain. Kannel  and  colleagues ,in  1984, analyzed  the  incidence  and  
prognosis  of  unrecognized  myocardial  infarctions  and  found  that  almost  half  of  
such  patients  did  not  have  chest  pain  and  such  silent  infarctions  were  higher   
in  women  and  in  older  men 53. In  1973, Margolis  and  associates  evaluated  the  
incidence , prevalence, characteristics,  and  prognosis  associated  with  clinically  
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unrecognized  myocardial  infarctions  diagnosed  by  ECG  changes. He  observed  
only  one  third  of  men   with  unrecognized  and  58%  of   men  with  recognized  
infarctions  had  history  of  angina  pectoris (p ≤  0.001)54. In  1965,  Massumi  et  al  
observed  as  many  as  52%  of  patients  with   congestive  cardiomyopathy  report  
chest  pain  despite  the  presence  of  normal  coronary  arteries . Pasternac (1982)  
explained  that  the  chest  pain  in  idiopathic  dilated  cardiomyopathy  is  due  to  
decreased  myocardial  perfusion ,both  at  rest  and  during  pacing  leads  to  
subendocardial  ischemia. In  his  study  he  observed  three  of  five  patients  with  
idiopathic  congestive  cardiomyopathy  had  chest  discomfort 8.  Vigna  et  al,  in  
1996, have  shown  that  angina  was  present  in  53%  of  patients  with  ischemic  
DCM  and  36%  of   patients  with  nonischemic  DCM (p= 0.994). From  these  
observations  it  is  evident  that  patients  with  ischemic  and  nonischemic  DCM  
can not  reliably  be  distinguished  on  the  basis  of  presence  or  absence  of  chest  
pain.  
Ischemic  cardiomyopathy  may  be  suspected  on   the  basis  of  
electrocardiographic  findings. However,  the  sensitivity  and  specificity  of  these  
data  are  often  inadequate  for  individual   patient  management  decisions   and  
further  confounded  by  the  frequent  presence  of  a  nondiagnostic   ECG  with  
conduction  abnormalities. In  1964, Tavel  et  al   in  his  original  article  of   
‘abnormal Q  waves  simulating  myocardial  infarction  in  diffuse  myocardial  
diseases’   he   demonstrated  that  patients  with  nonischemic  myocardial  diseases  
frequently  had  abnormal  Q  waves 21. In  his  study  54%  of  patients  with  
nonischemic  DCM  had  pathological  Q waves .On  the  contrary, some  patients  
with  left  ventricular  dysfunction  due  to  coronary  artery  disease  may  not  have  
ECG  changes  suggestive  of   ischemia. In  1984,  of  708  myocardial  infarctions 
among  5127  participants  in  the Framingham   study   Kannel  et  al  had  shown  
that  24%  of  patients  with  coronary  artery  disease  by  echocardiography  did  not  
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demonstrate  any  ECG  changes  of  coronary  artery  disease. The  sensitivity  and  
specificity  of  ECG  changes  is  further  confounded  by  frequent  presence  of  
conduction  abnormalities,  especially  LBBB. In  Duncan’s  study,  among  73  
patients  with  DCM  26  patients  had LBBB, 16 with  ischemic DCM  and  10  with  
nonischemic DCM. In   other  studies  also, LBBB  was  present   in  comparable   
numbers  in  doth  types  of  DCMs 68. 
RESTING   RWMA 
The  detection  of  left   ventricular  regional  wall  motion  abnormalities  by  
echocardiography  or  by   radionuclide  angiography  is  often  thought  to  be  a  
reliable  indicator  of  the  presence  of  significant  coronary  artery  obstruction  and  
prior  infarction 55.  However,  these  findings  have  been  recognized  in  patients  
with  nonischemic DCM  as  well 43,56. In  1984, Wallis  et  al 56  analyzed  fifty  
patients  with  idiopathic  DCM   by  radionuclide  ventriculography and  found  64%  
had  segmental  and  36%  had  diffuse   wall  motion  abnormalities.  Medina  et  al,  
in  1985  evaluated  the  usefulness  of  echocardiographic  regional  wall  motion  
abnormalities  in  detecting  coronary  artery  disease  in  patients  with  left 
ventricular  dysfunction  and  a  normal-sized  or  dilated  left  ventricle. 103  patients  
were  studied by  two-dimensional  echocardiography   and  cardiac  catheterization. 
In  60  patients  (group I)  who  had  LV  Dysfunction  and  a  dilated  left  ventricle  
by  echo (patients with dilated cardiomyopathy), RWMA  were  detected  in  44  
patients  and  36 (86%)  of  them  had significant  CAD, usually  two- or  three-vessel 
obstruction; of the 16 patients with dilated  cardiomyopathy (DCM)  and  diffuse  LV  
hypokinesis, eight (50%)  had  evidence  of  CAD.  Thus the presence   of   RWMA  
by  2DE  had  an  83%  sensitivity,  a  57%  specificity,  and  a  77%  predictive  
accuracy  in  detecting  CAD  in patients  with  DCM  and  thus  in  distinguishing  
ischemic  from  idiopathic   DCM. In 43  patients  with  LV  dysfunction  but  normal  
LV  size (group II),  the  sensitivity, specificity,  and  predictive  accuracy  of  RWMA  
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in  detecting significant CAD was 95%, l00%, and 95%, respectively. The finding, 
however, of  diffuse  LV  hypokinesis does  not  exclude  CAD  in  these  patients,  
especially  when  the  left  ventricle  is  dilated. Though  regional  wall  motion  
abnormalities  had  high  specificity  in  detecting  CAD  in  patients  with  severe  LV  
dysfunction   and  normal  LV  dimensions,  it  had  low  specificity(57%)  in   
patients  with  dilated  left  ventricle. This  study  has  also  other  limitations. The  
assessment  of  wall  motion  abnormalities  by  2DE was qualitative  and  subjective  
and  may  be  affected  by  inter- or intraobserver  variability. The  finding  of  CAD  
in  patients  with  DCM  does  not  necessarily  imply  that  CAD was  the  cause of  
congestive  cardiomyopathy. A  causal  relationship  between  the  two  entities  is not  
definitely  established  in  this  study. 
Diaz  and  colleagues, in  1991,  studied  the  value  of    two-dimensional  
echocardiography  in  differentiation  of  congestive  and  ischemic  cardiomyopathy. 
Of  70  total  patients  with  chronic  heart  failure  36  patients  had  nonischemic  
DCM  and  34  had  ischemic  DCM.  RWMAs  were  detected  in  44%  of  
nonischemic  and  65%  of   patients  with  ischemic  DCM. Diffuse  wall  motion  
abnormalities  were  present  in 56%  of  patients  with  nonischemic  DCM   and  
35%  of  patients  with  ischemic  DCM . Regional  dyssynergy  in  primary  DCM  is  
likely  because  of  microcirculatory  involvement   and  myocardial  hypoperfusion 6,7. 
He  concluded  that  2D  echocardiography  was  not  useful  in  patients  with  chronic  
heart  failure  to  differentiate  dilated  and  ischemic  cardiomyopathy.  From  the  
above  observations  it  is  clearly  evident  that  presence  of  RWMAs  do  not  
accurately  identify  patients  with  ischemic  DCM  and  presence  of  global  
hypokinesia  may  not  reliably  exclude  ischemic  DCM     
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DOBUTAMINE  STRESS   ECHOCARDIOGRAPHY (DSE ) 
Echocardiography  performed  at  rest  is  widely   used  to  evaluate  patients   
with  dilated  cardiomyopathy. Unfortunately,  the  frequency  of  regional  wall  
motion  abnormalities  at  rest  in  nonischemic  cardiomyopathy  and  the  presence  
of  global  dysfunction  in  patients  with  advanced  ischemic  cardiomyopathy  
prevent  accurate  identification  of  coronary  artery   disease 6,7. Exercise  testing  is  
the  standard  noninvasive  method  used  for  detection  of  coronary  artery  disease  
in  patients  without  dilated  cardiomyopathy. It  is  not  routinely  used  for  
diagnostic  for  diagnostic  purpose  in  patients  with  dilated  cardiomyopathy   
because  of  their  reduced  ability  to  perform  exercise  testing. Additionally,  the  
frequency  of  ECG  abnormalities  at  rest  impairs  interpretation  of  the  stress   
ECG.  Dobutamine  stress echocardiography  has  been found  to  accurately  
identifies  patients  with  coronary  artery  disease    with  major  advantage  that  it  is  
not  dependant  on  patient’s  ability  to  exercise. 
Previous studies have shown that dobutamine stress echocardiography safely 
and accurately identifies coronary artery disease in patients without dilated 
cardiomyopathy. All  these  studies  were  done  in  patients  with  normal  sized  
ventricle. Sharp et  al, 1994 15  were the  first  one attempted to determine the safety 
and accuracy of  dobutamine stress echocardiography for detection of coronary artery 
disease in patients with dilated cardiomyopathy. He  tried  to  determine  whether  
stress  induced  changes  in  wall  motion  could   distinguish  patients  with  coronary  
artery  disease  from  those  without.  Seventy  patients  with  dilated  cardiomyopathy  
underwent  dobutamine  stress echocardiography. Echocardiograms  were  obtained  
at  baseline and  at  low (5 to 10 micrograms/kg  body  weight  per  min)  and  peak  
doses  of  dobutamine.  Rest  and stress  left  ventricular  wall  motion  scores  were  
derived  from  analysis of regional wall motion. Fifty-four subjects underwent 
coronary angiography. Dobutamine infusion was terminated after achievement of the 
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target heart rate or maximal protocol dose in 49 patients (70%), ischemia in 12 (17%), 
arrhythmia in 4 (6%) and side effects in 5 (7%). No patient had prolonged ischemia or 
sustained arrhythmia. Of those with angiographic studies, 40 had significant coronary 
artery disease (> or = 50% diameter stenosis). Use of the change in global wall motion 
score index from low to peak dose resulted in a sensitivity of 83% for dobutamine 
stress echocardiography and a specificity of 71% for detection of coronary artery 
disease. Sensitivity for detection of triple-, double- and single-vessel disease was 
100%, 83% and 69%, respectively. He  concluded  that  dobutamine stress 
echocardiography safely provides diagnostic information in patients with dilated 
cardiomyopathy. This technique has high sensitivity for multivessel coronary artery 
disease but only moderate specificity. In this  study  patients  with  history  of  MI  
were  also  included  where the  etiology  of  left  ventricle  dysfunction is  obvious   
Moreover, analysis  of  wall   motion  was  limited  to  qualitative  techniques.  
In  1996,  Vigna  and  colleagues 16  studied  43  patients  with  left ventricular 
dysfunction   by dobutamine  stress  echocardiography   to  distinguish  between  
ischemic  and nonischemic  dilated  cardiomyopathy.  He  selected  patients  less than  
70  years  old  with  DCM (LVIDd > 6.0 cm and LVEF  < 40%)  and  without  history  
or  ECG  evidence  of   previous  MI At rest, there were more normal segments (p < 
0.001) and a trend toward more akinetic segments (p, not significant) per ischemic 
than per nonischemic DCM patient. However, either at rest or with low-dose 
dobutamine, individual data largely overlapped. At peak dose, in ischemic DCM, 
regional contraction worsened in many normal or dyssynergic regions at rest (in the 
latter case after improvement with low-dose dobutamine); in contrast, in nonischemic 
DCM, further mild improvement was observed in a variable number of left ventricular 
areas. Thus with peak-dose dobutamine, more akinetic and less normal segments were 
present per ischemic than per nonischemic DCM patient (both, p < 0.001). A value of 
six or more akinetic segments was 80% sensitive and 96% specific for ischemic 
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DCM. His   data show that analysis of regional contraction by dobutamine stress 
echocardiography can distinguish between ischemic and nonischemic DCM 16.  His  
study  has  some  limitations. He  did  not  perform  side-by-side  comparisons  of  
wall  motion  on  the  digitized  quad-screen  format,  so  possibility  of  missing  
subtle  responses  to  dobutamine   in   patients  with  diffuse  or  severe  wall   motion  
abnormalities. Moreover   patients  with  single  vessel   disease  frequently  did  not  
develop  significant  worsening  of  segments  with  peak  dose  dobutamine, so  the  
sensitivity  of  differentiating  ischemic  DCM  with  single  vessel  disease  and  
nonischemic  DCM  is low. 
 Cohen  et  al,  in  1997  studied   whether  DSE  is useful  in  differentiation  
of   cardiomyopathy 61.  Dobutamine stress echocardiography was performed in 56 
consecutive patients, mean age: sixty-two +/- twelve years. Twenty-two patients had 
an idiopathic dilated cardiomyopathy (group 1) and 34 had angiographically proven 
ischemic dilated cardiomyopathy (group 2). Wall motion score index and left 
ventricular ejection fraction were determined at baseline, 5 micrograms/kg/min, peak, 
and ten minutes after stepwise dobutamine infusion. Worsening or no change in 
global wall motion score was observed in 9 group 2 patients (26%) and 1 group 1 
patient (5%, P = .07). No significant difference was observed with regard to wall 
motion score index decrease between baseline and peak dose. Left ventricular ejection 
fraction increase during dobutamine infusion was comparable in both groups. Thus, 
an ischemic response was observed more often in the coronary artery disease group, 
yielding a good specificity and positive predictive value although sensitivity was low. 
However, left ventricular function improvement did not help to discriminate patients 
with or without significant CAD. 
Franchini 60 , in  2000,  aimed  to  assess  the  values  of  high-dose  
dobutamine  stress  echocardiography  and  of  Thallium-201  SPECT (exercise-
reinjection-rest protocol)  in  differentiating  between  ischaemic  and  non-ischaemic 
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dilated  cardiomyopathy in   37  patients  with  suspected  myocardial  ischemia,  low 
ventricular  ejection  fraction (23±5%)  and  heart  failure. Coronary  artery  disease  
was defined  as  >50%   coronary  stenosis  in  at  least  one  coronary  artery. By  
dobutamine stress  echocardiography, ischaemic  dilated  cardiomyopathy  was  
considered  present when  either  an ischaemic  response  (biphasic  response  or  
direct  deterioration)  or   a scar (fixed dyssynergy)  was  documented  in  atleast  two  
segments. Twenty-three patients  had ischaemic  dilated  cardiomyopathy,  while  14  
had  normal  coronary arteries. The  presence  of  myocardial  ischaemia  and/or  scar  
by  dobutamine  stress echocardiography  identified  patients  with  ischaemic  dilated  
cardiomyopathy  with  a sensitivity  of  100%  and  a  specificity  of  86%.  Three  of  
the  four  false  positive results  occurred  in  patients  with  left  bundle  branch  
block. He  concluded   that  dobutamine  stress  echocardiography  is  a  sensitive 
technique for detecting the ischaemic aetiology of dilated cardiomyopathy. However, 
the specificity is lower  particularly   when  left  bundle  branch  block  is  present. 
THALLIUM –DIPYRIDAMOLE    SCINTIGRAPHY 
 Thallium 201 myocardial perfusion imaging and technetium 99m human 
serum cardiac blood pool scanning with technetium 99m human serum albumin allow 
noninvasive evaluation of left ventricular myocardial perfusion  and function. 
Thallium 201 myocardial perfusion imaging   has proved useful in evaluation of 
coronary artery disease. Thallium 201 uptake reflects not only coronary perfusion but 
myocardial viability as an agent that is actively taken up and   concentrated by the 
myocardial cell. Areas of myocardium  devoid of viable muscle for whatever reason 
appear as "coldspots" on the thallium 201 image. Technetium 99m human  serum 
albumin gated cardiac blood pool scanning provides a  noninvasive evaluation of 
ventricular function. Left ventricular ejection fraction determined by this technique 
has correlated well with standard left ventricular contrast angiography. The combined 
use of these techniques had been   useful in the detection and localization of 
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myocardial infarction. They have also been found to be useful in the evaluation of 
primary hypertrophic, and secondary cardiomyopathies. The purpose of the present 
study was to determine whether these noninvasive techniques could be used to  
distinguish ischemic from primary idiopathic congestive cardiomyopathy. 
Bernadine  and  associates,  in  1977 62  evaluated radioisotope images of the 
heart in 13 patients with ischemic, and eight patients with idiopathic congestive 
cardiomyopathy, and 14  patients with normal hearts. Diagnosis was established by 
cardiac  catheterization and/or autopsy in each of the 35 patients. The 14  normals 
could be readily distinguished from cardiomyopathy, and ischemic could  be 
distinguished from idiopathic dilated cardiomyopathy in 20 of 21 patients. All patients 
with cardiomyopathy showed hypokinetic and dilated left ventricles, but right 
ventricular  dilatation was evident mainly in those with idiopathic CM. TI images in 
the ischemic type had defects of greater than 40% of image  circumference which 
corresponded to segmental wall motion abnormalities on gated  cardiac  blood  pool 
scans(GCBPS), whereas those with the idiopathic congestive form were homogeneous 
or had defects of less than 20% of image circumference. Autopsy studies in 7 of 35 
patients correlated TI defects of greater than 20% of circumference with transmural 
myocardial fibrosis. 
Iskandrian et al, in  1986  examined the usefulness of resting  thallium-201 
myocardial scintigraphy in differentiating patients with primary cardiomyopathy from 
those  with “ischemic” cardiomyopathy 63. The 60 patients included in this study were 
those who had severe LV dysfunction with ejection fraction  less than 35% as 
determined by radionuclide angiography, and in whom resting thallium- 201 images 
were available. The patients were divided into three groups: group I (n = 15) had 
primary cardiomyopathy based on the normal coronary angiograms or <5 % 
probability of CAD according to age, sex, symptoms, ECG findings, and coronary 
risk factors such as a history of diabetes mellitus, hypertension, abnormal lipid levels, 
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smoking, and a family history of premature atherosclerosis. The patients in group II (n 
= 20) had CAD documented by coronary angiography, which showed ~50% diameter 
narrowing of one or more vessels. The patients in group III (n = 25) comprised 
consecutive patients (21 men and four women, all  between 31 and 77 years of age) 
with acute myocardial infarction in whom radionuclide. and thallium-201 
scintigraphic studies were available -7 to 10 days after the infarction. The diagnosis of 
acute infarction was documented by a typical history of prolonged chest pain, 
appearance of abnormal Q waves, and serum enzyme changes. Resting thallium-201 
myocardial scintigrams were obtained in all patients after overnight fasting, with the 
use of intravenous injections of 2 mCi of thallium-201. Twenty minutes after 
injection, thallium images were obtained in three projections (anterior, 30-degree left 
anterior oblique, and 65-degree left anterior oblique). Redistribution images were 
obtained 4 hours after injection. Most patients with primary cardiomyopathy  had 
normal or near-normal thallium perfusion scans; thus 12 patients had either no 
defects, only myocardial thinning, or 13 abnormal segments. Of the 20 patients in 
ischemic  cardiomyopathy group , 19 had  more than 3  perfusion defects. The only 
patient with no perfusion defects on the initial scan had a diffuse abnormal washout 
pattern on the delayed study consistent with resting hypoperfusion. The thallium 
distribution pattern was different among the three groups . Extensive perfusion defects 
were present in only one patient in group I, whereas they were seen in 95% of patients 
in group II and 100% of the patients in group III. The thallium score was significantly 
higher (less abnormal) in group I than in the remaining two groups; only one patient 
in group I had a score <50, whereas 17 patients (85% ) in group II and 25 patients 
(100% ) in group III had scores ~50 (Fig. 3). The right ventricular and lung thallium 
uptake were not significantly  different in the three groups. The  limitation  of  this  
study  was  not  all patients  with primary  cardiomyopathy underwent coronary 
arteriography; The  author   explained   that patients who did not undergo 
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arteriography are unlikely candidates for CAD because of their age, sex, symptoms, 
and coronary risk factors.  
 Eichhorn   and   colleagues (1988) assessed the Usefulness of Dipyridamole-
Thallium-201 Perfusion Scanning for Distinguishing Ischemic from Nonischemic 
Cardiomyopathy 17. To determine noninvasively the etiology of left ventricular (LV) 
dysfunction, 22 patients with a diagnosis of cardiomyopathy determined via cardiac 
Cath- eterization and 5 normal control subjects underwent radionuclide 
ventriculography and intravenous dipyridamole-thallium-201 perfusion scanning. 
Both ischemically and nonischemically induced LV dysfunction had comparable 
global LV  ejection fractions (24 +/- 6 vs 23 +/- 8%, respectively) and extent of 
segmental wall motion abnormalities.Right ventricular ejection fraction was 
significantly better in the group with an ischemic etiology of LV dysfunction (41 +/- 
26 vs 13 +/- 10%, p <0.005) but significant group overlap was present. However, 
computer-assisted analysis of dipyridamole-thallium-201 myocardial perfusion 
scanning demonstrated more homogeneous  myocardial  perfusion  in  idiopathic  
cardiomyopathy  ( mean   perfusion defect  25 +/- 11 vs 6+/- 6%, p <0.00l) and 
successfully predicted the correct etiology of LV dysfunction in 20 of 22 (91%) 
patients. 
The basis for the difference in Tl-201 perfusion appears to reflect both 
differences in potential homogeneous increase of coronary blood flow and myocardial 
cellular metabolic activity. Coronary artery disease patients  with substantial LV 
dysfunction frequently have  occluded coronary arteries supplying the infarcted zone. 
Therefore, Tl-201 is unable to reach the myocardial cell for subsequent uptake. In 
addition, the myocardium is frequently replaced with extensive fibrous tissue 
metabolically unable to accumulate Tl-201. In contrast, idiopathic  cardiomyopathy, 
although it exhibits a lower 
 23
than normal myocardial blood flow per unit mass, is  still capable of increasing flow 
to all areas after a metabolic  stress such as atria1 pacing. The lower myocardial 
perfusion found in dilated cardiomyopathy reflects  the decreased myocardial 
metabolic demands resulting  from the depressed functional characteristics of the 
cardiomyopathic ventricle. Although both ischemic and idiopathic  cardiomyopathy 
patients exhibit decreased total coronary blood flow, the coronary artery disease 
patients  have greater heterogeneity of regional myocardial   perfusion. This is 
accentuated by dipyridamole and  therefore results in successful delineation of these 2 
entities. 
  Thallium-201 scintigraphy is an accepted modality in the evaluation of 
atherosclerotic  cardiovascular disease; however, uptake is dependent on myocardial 
mass and cellular extraction in addition  to coronary perfusion.4 Therefore, 
scintigraphic defects at  rest  may occur independently of perfusion deficits in a 
dilated  left ventricles Tauberg  et  al,  in  1993 51, examined whether idiopathic 
dilated cardiomyopathy  could be distinguished from ischemic cardiomyopathy  by 
using parameters of defect size, severity  and reversibility obtained from quantitative 
and  qualitative assessment of exercise and redistribution thallium  scans. Thallium-
201 exercise testing was performed in 51 patients with coronary arteriography 
referred for evaluation of severe congestive heart failure. All patients had a left 
ventricular ejection fraction < 35%. Thirty-one ischemic patients had coronary 
stenosis > 70% in   one or  more  than one artery, and 20 idiopathic patients had no 
coronary stenosis or identifiable cause of heart disease. Similar exercise capacity, 
ejection fraction and sex distribution were found in both groups. Ischemic patients 
more often had severe perfusion defects (97 vs 25%; p = 0.00001), large perfusion 
defects involving > or = 40% of the left ventricular contour (100 vs 80%; p = 0.01), 
and increased thallium-201 lung uptake (94 vs 65%, p = 0.01). Large severe defects 
were present in 90% of ischemic and only 5% of idiopathic patients. On quantitative 
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analysis, the area of the thallium-201 curve less than normal was greater in ischemic 
than idiopathic patients (14.8 +/- 9.5% vs 3.3 +/- 2.8%; p = 0.001). The degree and 
severity of redistribution were similar in both groups. Multivariate analysis identified 
the qualitative parameters of increased thallium-201 lung uptake, severe defects and 
large severe defects as the only independent predictors of the presence of ischemic 
disease. The presence of large severe defects had a 97% predictive value for ischemic 
cardiomyopathy. The absence of severe defects had a 94% predictive value for 
idiopathic dilated. This  study  has  the  limitation  of  retrospective  data  collection. 
POSITRON EMISSION TOMOGRAPHY (PET) 
Eisenberg JD,in  1987  had  undertaken initiative to determine whether 
positron emission tomography (PET) performed after the intravenous injection of 
11C-palmitate permits differentiation of patients with ischemic from those with 
nonischemic dilated cardiomyopathy. PET was performed after intravenous injection 
of 11C-palmitate in 10 patients with ischemic and in 10 with nonischemic dilated 
cardiomyopathy. Regions of homogeneously severely depressed accumulation of 
11C-palmitate, representing 15% or more of the expected myocardial cross-sectional 
area, were observed in 8 of 10 patients with ischemic but in none of 10 patients with 
nonischemic cardiomyopathy. Patients with nonischemic cardiomyopathy had marked 
spatial heterogeneity of the accumulation of palmitate throughout the left ventricular 
myocardium, whereas most tomographic sections from patients with ischemic 
cardiomyopathy accumulated 11C-palmitate more homogeneously in regions 
exclusive of discrete defects indicative of remote infarction. Thus, a larger number of 
discrete noncontiguous regions (17 +/- 5 compared with 12 +/- 4, p less than 0.001) 
and greater reduction of average 11C-palmitate content (59 +/- 6 compared with 64 
+/- 10% maximal myocardial radioactivity, p less than 0.05) were seen in the 
tomographic reconstructions from patients with nonischemic than in those from 
patients with ischemic cardiomyopathy. These findings support the hypothesis that 
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multiple myocardial infarctions underlie the process seen as dilated cardiomyopathy 
in patients with coronary artery disease. These findings indicate that PET permits 
differentiation of patients with ischemic from those with nonischemic 
cardiomyopathy.This  study  is  limited  by  heterogenous  and  incompletely  
characterized  patient  groups,  and  discrimination  between  two  entities  was  based  
only  on  the  presence  of  discrete  infarctions  as  made  by  subjective  visual  
analysis 
 Mody et  al, in  1991,  determined if imaging of blood flow (using N-13 
ammonia) and glucose metabolism (using F-18 2-deoxyglucose) with positron 
emission tomography can distinguish cardiomyopathy of coronary artery disease from 
nonischemic dilated cardiomyopathy. 21 patients with severe left ventricular 
dysfunction who were evaluated for cardiac transplantation were studied. The origin 
of left ventricular dysfunction had been previously determined by coronary 
angiography to be ischemic (11 patients) or nonischemic (10 patients). Images were 
visually analyzed by three observers on a graded scale in seven left ventricular 
segments and revealed fewer defects in dilated cardiomyopathy compared with 
ischemic cardiomyopathy for N-13 ammonia (2.7 +/- 1.6 versus 5 +/- 0.6; p less than 
0.03) and F-18 deoxyglucose (2.8 +/- 2.1 versus 4.6 +/- 1.1; p less than 0.03). An 
index incorporating extent and severity of defects revealed more homogeneity with 
fewer and less severe defects in subjects with nonischemic than in those with 
ischemic cardiomyopathy as assessed by imaging of flow (2.8 +/- 1.8 versus 9.2 +/- 3; 
p less than 0.001) and metabolism (3.8 +/- 3.3 versus 8.5 +/- 3.6; p less than 0.005). 
Diagnostic accuracy for distinguishing the two subgroups by visual image analysis 
was 85%. Using previously published circumferential count profile criteria, patients 
with dilated cardiomyopathy had fewer ischemic segments (0.4 +/- 0.8 versus 2.5 +/- 
2 per patient; p less than 0.01) and infarcted segments (0.1 +/- 0.3 versus 2.4 +/- 1.4 
per patient; p less than 0.001) than did patients with cardiomyopathy of coronary 
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artery disease. The sensitivity for differentiating the two clinical subgroups using 
circumferential profile analysis was 100% and the specificity 80%. An index 
incorporating both number and severity of defects derived from circumferential 
profile analysis was significantly lower in subjects with dilated cardiomyopathy than 
in ischemic cardiomyopathy (0.3 +/- 0.8 versus 2.7 +/- 2.4; p less than 0.005). Thus, 
noninvasive positron emission tomographic imaging with N-13 ammonia and F-18 
deoxyglucose is helpful in distinguishing patients with severe left ventricular 
dysfunction secondary to coronary artery disease from those with nonischemic 
cardiomyopathy, and a semiquantitative index such as circumferential profile analysis 
is superior to that of visual analysis   alone. The  main  problems  with  PET  are  its  
nonavailability  and  high  cost . 
ELECTRON BEAM COMPUTED TOMOGRAPHY(EBCT) 
 Multiple studies have demonstrated a strong correlation between the  presence 
of coronary calcium and obstructive CAD .Electron beam computed tomography 
(EBCT), by acquiring   x-ray images of the coronary arteries, detects the presence of  
coronary calcium, which is invariably an indicator of intimal atherosclerosis . Budof  
et al, in  1998,  evaluated  the ability of  EBCT  to distinguish ischemic  from 
nonischemic causes of cardiomyopathy by evaluating  heart failure patients for 
coronary calcification (CC).  One hundred and twenty-five patients with 
cardiomyopathy (ejection fraction <0.40) and known coronary anatomy underwent  
EBCT coronary scanning to evaluate for CCs within 3 months of coronary 
angiography. Of the 72 patients who were found to have ischemic cardiomyopathy, 71 
patients had CC by EBCT (sensitivity 99%, p < 0.001), mean score 798 ± 899. In 
comparison, among  the 53 patients without significant coronary artery disease (CAD) 
(nonischemic cardiomyopathy), the mean score was significantly lower (17 ± 51; p < 
0.0001), and 44 patients had a CC score of 0 (no CC present). The specificity of 
EBCT to exclude CAD in patients with cardiomyopathy was 83%, using a threshold 
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CC score of 0, and 92% for scores <80 (p < 0.001). Overall accuracy for determining 
the etiology of cardiomyopathy (differentiating ischemic from nonischemic) was 92% 
for this technique. In  this  study  many  many the ischemic patients had hypertension, 
a  potential cause of nonischemic cardiomyopathy.  
CAROTID   ATHEROSCLEROSIS 
Extracranial carotid artery disease has been strongly associated with increased 
prevalence of significant coronary   atherosclerosis and acute coronary events, and 
vice versa. Furthermore, both coronary and carotid arterial trees share many risk 
factors that contribute to the atherosclerotic process. Ultrasonic scanning is a reliable 
and feasible technique to detect carotid disease. Therefore, Androulakis  et al , in 
2000,prospectively examined the value of carotid atherosclerosis in the prediction of 
coronary artery disease as the underlying cause of diffuse left ventricular dilatation 
and dysfunction in cases of undetermined aetiology 65. In this  study  Seventy-eight 
patients with undetermined dilatation and diffuse impairment of the left ventricular 
contraction were studied within 28 months. They underwent carotid scan and 
coronary arteriography. Carotid atherosclerosis was found to be very common in 
ischaemic and rare in non-ischaemic cardiomyopathy. The presence of at least one 
abnormal carotid finding (intima–media thickness >1 mm, plaques, severe carotid 
stenosis) was 96% sensitive and 89% specific for ischaemic cardiomyopathy. Thus 
carotid scanning may be a useful screening and decision making tool in patients with 
cardiomyopathy of indecisive cause. Patients with carotid atherosclerosis are likely to 
suffer from severe coronary artery disease. Coronary angiography and subsequent 
myocardial viability studies, when indicated, could be considered early during their 
evaluation. In contrast, a negative carotid scan predicts non-ischaemic 
cardiomyopathy. Limitations  of  this  study  are  six false–positive results of the 
carotid scanning were observed in individuals older than 65 years and in this age 
group abnormal carotid findings are more common. It is likely that the sensitivity and 
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specificity of carotid imaging in predicting coronary artery disease is very much 
dependent on age and sex. Intima–media thickness was measured in not as detailed a 
fashion as in most studies implicating it as a risk factor for vascular disease. Instead, 
the highest value at the distal common carotid artery was taken into account. 
MAGNETIC   RESONANCE   IMAGING (MRI) 
 The value of cardiovascular magnetic resonance (CMR) in the treatment of 
heart failure is becoming established in initial functional assessment and in the 
determination of secondary causes. Gadolinium-enhanced CMR can also characterize 
areas of myocardial  infarction, and limited results suggest that gadolinium 
enhancement is absent in nonischemic LV dysfunction. Based  on  these  
observations, McCrohon and  associates , in  2003 66  evaluated whether gadolinium 
enhancement might be a useful clinical tool in distinguishing  LV dysfunction related 
to DCM or CAD and whether it may also offer new insights in DCM. Late 
gadolinium enhancement with CMR was performed in 90 patients with heart failure 
and LV systolic dysfunction (63 patients with DCM and unobstructed coronary 
arteries and 27 with significant CAD at  angiography). We also studied 15 control 
subjects with no coronary risk factors and/or unobstructed coronary arteries. None 
(0%) of the control subjects had myocardial gadolinium enhancement; however, all 
patients (100%) with LV  dysfunction and CAD had enhancement, which was 
subendocardial or transmural. In patients with DCM, there were 3  findings: no 
enhancement (59%); myocardial enhancement indistinguishable from the patients 
with CAD (13%); and  patchy or longitudinal striae of midwall enhancement clearly 
different from the distribution in patients with CAD (28%).The  author demonstrated  
that  Gadolinium CMR is a powerful technique to distinguish DCM from LV 
dysfunction related to CAD . These data suggest that using the coronary angiogram as 
the arbiter for the presence of LV dysfunction caused by CAD could have lead to an 
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incorrect assignment of DCM cause in 13% of patients, possibly  because of coronary 
recanalization after infarction.  
VALVULAR  AND  THORACIC  AORTIC  CALCIFICATIONS 
Cardiac valvular and thoracic aortic calcifications have previously been 
reported to be  used as a window to diffuse atherosclerosis of the vascular system. In 
2004, Ramazan atak  and  colleagues  prospectively  examined the predictive value of 
mitral annular calcification (MAC), aortic valve calcification(AVC), and thoracic 
aortic calcification (TAC) in diagnosis of coronary artery disease as  the underlying 
cause of diffuse left ventricular dilatation and systolic dysfunction. The study  
included 98 consecutive patients (male/female = 76/22, mean age = 58.9 ±10.7 years, 
range:33 to 75 years) over the age of 30 years admitted to their clinics between 
October 1999 and  December 2001 with signs and symptoms of congestive heart 
failure associated with documented  cardiomegaly. Transthoracic  echo cardiography 
and coronary angiography were  performed in all patients for the evaluation of 
valvular calcifications and coronary status. Patients with a left ventricular end-
diastolic diameter >4 cm/m2 and a  left ventricular ejection fraction <45% according  
to the modified Simpson method were considered  eligible for the study. Two-
dimensional assessment of the aortic valve was done from the  parasternal long and 
short axis and apical 4-chamber views. Aortic valve calcification was defined  as 
bright dense echoes of >1 mm size on 1 or more cusps without restriction of leaflet 
motion. Criteria for MAC included an intense echoproducing structure located at the 
junction of the atrioventricular groove and posterior mitral valve leaflet on 2-
dimensional examination. The diagnosis  of TAC was assessed with the use of chest  
roentgenograms in which the x-ray tube was  placed at the level of the seventh 
thoracic vertebra,  at a distance of 2 meters. Calcified plaques  were accepted as 
present when typically shaped  densities were seen in the aortic arch or in the 
descending  part of the thoracal aorta. Selective coronary angiography and left 
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ventriculography  were performed percutaneously by  Judkins technique.  Luminal 
diameter narrowing  over 50% in 1 or more epicardial coronary  arteries was 
considered as significant coronary  artery stenosis. Although there was no significant 
difference between the groups with and without coronary  artery stenosis (CAS), with 
regard to presence of MAC, patients with CAS tended to have  MAC more frequently 
(12/61, 20% vs 4/37, 11%, p>0.05). AVC and TAC were found to be significantly  
more frequent in patients with CAS compared to those without CAS (AVC, 35/61, 
57%  vs 4/37, 11%, p<0.001 and TAC, 28/61, 46% vs 2/37, 5%, p<0.001). While all 3 
calcifications had  sensitivity under 60%, and specificity and positive predictive value 
over 75% individually, the  presence of any of them had a sensitivity of 80%, 
specificity of 86%, positive predictive value  of 91%, and negative predictive value of 
73%. Thus the presence of any of these calcifications  distinguished patients with 
coronary artery disease with a sensitivity of 80% and specificity  of 86%. The 
presence of aortic valvular valve and thoracic aortic calcifications seems to  be 
associated with significant coronary arterial stenosis; however, with relatively low 
negative  predictive values these cannot be used in clinical practice for diagnosis of 
underlying coronary  artery disease in patients with dilatated left ventricles and 
impaired systolic functions. 
LONG AXIS   FUNCTION   OF  VENTRICLES 
Left ventricular fibres are predominantly arranged longitudinally or obliquely 
in the subendocardium and subepicardium and circumferentially in the intermediate 
layers. The important contribution of longitudinally arranged fibres to overall 
ventricular function has been recognized for many years. During ventricular systole, 
long axis function has a major role in maintaining normal ejection fraction and 
associated changes in left ventricular cavity shape   It has been appreciated since the 
time of  William Harvey that normal left ventricular  contraction involves the 
coordinated action of  circumferentially and longitudinally directed fibres. During 
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early systole, the longitudinal and oblique fibers begin to contract first causing the 
long-axis to  shorten, moves  the  mitral annulus  towards  the apex and the left 
ventricular cavity to become more spherical. After a mean delay of 25 (SD 40) ms, 
the  circumferential fibres also begin to contract which  causes transverse shortening 
and throughout the rest of systole both circumferential and  longitudinal axes contract 
synchronously. Both the extent and timing of shortening and thickening of 
longitudinal fibers is essential to normal systolic function. Detailed observations using 
the superior repetition rate of M mode echocardiography demonstrate that shortening 
of the long axis begins during the period of isovolumic contraction. Peak long axis 
shortening occurs at A2 or aortic valve closure,  The longitudinal fibers are distributed  
mainly subendocardially which makes them more vulnerable than the circumferential 
fibers to the effects of myocardial ischaemia. This is due to a combination of 
increased wall stress during systole and a limited capacity for the subendocardial 
arterioles to vasodilate compared with those in the intermediate and epicardial layers. 
Shortening and lengthening patterns of the longitudinally directed fibres are 
frequently abnormal in coronary artery disease. These disturbances were both systolic 
and diastolic in timing. In systole, there was a reduction in total long axis excursion, 
delayed onset of shortening with respect to the Q wave of the ECG, and reduced 
shortening velocity. In diastole, the onset of lengthening with respect to the second 
heart sound was delayed, early diastolic lengthening velocity was reduced, and 
relative A wave excursion was increased. 
In view of the preponderance of circumferential fibres, it seems logical to 
deduce underlying myocardial function from the extent and velocity of their 
shortening; however, the picture of the underlying function reached from observing 
changes in left ventricular minor axis is at first sight surprising. Normal dimensions 
fall by 25–40% during ejection, while the normally loaded sarcomere shortens by 
only 10–12%.4 Furthermore, this remarkable fall in minor axis is the result of 
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thickening of the posterior wall to an extent much greater than would be expected 
from simultaneous inward movement of the epicardium  . This apparent increase in 
myocardial mass that must underlie the observed extent of thickening can only be 
explained by concurrent shortening, and thus transverse thickening, of the 
longitudinally directed fibres. Without this longitudinal component, normal sarcomere 
shortening would lead to a shortening fraction of 12% and an ejection fraction of less 
than 30%. Thus, even normal changes in    minor axis with ejection can be explained 
only on the basis of the combined action of the circumferential and longitudinal 
fibres. This suggests that the function of the latter might well be worth considering in 
its own right. The ventricular long axes both run from the apex to the base of the 
heart. The apex is clearly defined anatomically; the exact point used to locate the base 
has varied in different studies, but the most convenient has been the atrioventricular 
rings. It is possible to  consider points around them separately—for example, septal 
and left ventricular or right ventricular free wall or to take a mean value. Long axis 
measurements can thus be made using any imaging method that demonstrates the 
ventricular cavity. Furthermore, it was demonstrated more than 60 years ago by 
Hamilton that the cardiac apex is fixed with respect to the chest wall.8 It follows that 
changes in long axis are actually measured by changes in the position of the 
atrioventricular rings or planes. As single structures, their position can be followed 
directly by M mode  echocardiography and their velocity determined directly by 
Doppler. The long axis passes from the fibrous apex to the fibrous atrioventricular 
ring. Unlike with the minor axis, the extent of long axis shortening is not modified by 
changes in the minor axis. Measurements are thus simpler to interpret than those of 
the minor axis. 
Long axis motion of the atrioventricular rings reflects longitudinal ventricular 
shortening and lengthening, and the extent and timing can conveniently be assessed 
with M mode echocardiography. The velocity of shortening and lengthening can be 
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measured using digitised M modes or tissue Doppler. Because the majority of the 
longitudinally arranged fibres are located in the subendocardium, long axis function 
therefore largely reflects subendocardial function. This is therefore useful in 
assessment of the consequences of ischaemia, to which the subendocardium is 
particularly sensitive. 
Cross sectionally guided M mode echocardiograms of the left ventricular long 
axis can be obtained by longitudinal  placement of the M mode cursor through the 
lateral aspect of the mitral annulus and central fibrous body, visualized on the apical 
four chamber view. Similarly, right ventricular long axis function can be obtained by 
placing the cursor through the lateral aspect of the tricuspid annulus. Motion of the 
apex, with respect to the transducer placed at the apex, is insignificant, thus overall 
lengthening and shortening of the long axis of the left or right ventricles is truly 
reflected by atrioventricular annular motion. 
Pattern of long axis motion 
The normal pattern of long axis motion is characteristic. Shortening of the 
long axis slightly precedes that of the minor axis,  accounting for the characteristic 
change in cavity shape during isovolumic contraction. Peak inward motion of the long 
axis is synchronous with that of the minor axis and aortic closure. The proportional 
shortening of the long axis is, however, less than that of the short axis so that the 
ventricle becomes less spherical during contraction. Normal diastolic lengthening of 
the long axis commences promptly following mitral opening. There is little change in 
the long axis  during diastasis, but atrial contraction pulls the ring up, with further 
lengthening before subsequent systolic shortening. Thus examination of longitudinal 
axis M mode echocardiograms can also provide useful information regarding  
mechanical atrial activity.6 Both mitral and tricuspid annular motion may be 
examined in this way. Systolic descent of the annulus 
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 The timing and coordination of events is characteristically disturbed in 
coronary artery disease with delayed onset of contraction, prolonged shortening 
beyond aortic closure, and abnormal lengthening during early systole.These effects 
can be reversed by successful coronary angioplasty.The subendocardial fibres are 
particularly at risk in patients with dilated cardiomyopathy, both from the effects of 
any large or small coronary disease which may be present, but also from the indirect 
effects of raised left ventricular diastolic pressures In severe ventricular disease there 
are further characteristic abnormalities. Motion of the mitral annulus is greatly 
reduced or absent,7 and this has been used both in predicting prognosis,14 and as a 
surrogate for ejection fraction.5Typically, not only is the extent of shortening reduced, 
but the rates of both shortening and lengthening are as well. 
TISSUE    DOPPLER   IMAGING (TDI) 
 Tissue  Doppler  imaging(TDI)  is  a  novel  use  of  ultrasound  to  image the  
motion  of  tissue   with  Doppler  echocardiography. Doppler  echocardiography  
records  and  displays  the  velocities  of  the  moving  targets . When  Doppler  
echocardiography  is  used  to  measure  the  blood  flow  velocity ,  erythrocytes  are  
targets . Their  normal  velocity  ranges  from 10 cm/sec  in  the  venous  circulation  
to  150 cm/sec  in  the  arterial  circulation.  However,  the  velocities  of  myocardial  
tissue  are  much  lower (1-20 cm/sec ), but  their  amplitude  are  greater  than  those  
produced  by  blood. Therefore, Doppler  ultrasound  instruments  have  been  
modified  to  record  the  low  velocities  of  myocardial  tissue  and  to  reject  the  
high  velocities  generated  by  blood  flow. TDI  requires  a  high  frame  rate. A  
special  function  key  needs  to  be  selected  to  activate  TDI.  After  TDI  has  been  
selected,  the  subsequent   operation  is  identical  to  that  used  to  perform  regular  
pulsed  wave  Doppler  echocardiography,  except  that  TDI  gain   needs  to  be  
lowered  from  regular  gain  setting  used  for   blood  flow  Doppler  recordings  and  
velocity  scale  needs  to  adjusted  to  a  lower  aliasing  velocity (about  20-30  
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cm/sec  or  even  lower)  to  optimize  TDI  signals.  Also,    TDI  can  be   displayed  
in  the  color  mode,  just  as  in  color  imaging  of  blood  flow.  Tissue  velocities  
are  color-coded  by  autocorrelation: red  for  tissue  moving  towards  the  transducer  
and  blue  for  tissue  moving  away  from  transducer. Movement  and  velocities  of  
cardiac  structures  are  regulated  by  the  underlying  systolic  function  and  diastolic  
function  of  the  heart. 
 The  extent  of  systolic  movement  of  mitral  annulus  correlates  with  LV  
systolic  function  and  stroke  volume.  Normally,  the  systolic  velocity (Sa or  S’ )  
of  annulus  is  more  than  6 cm/sec. Early  diastolic  velocity  (Ea  or  E’ )  of  the   
mitral  annulus   measured  with  TDI  is  a  good  indicator  of  LV  myocardial  
relaxation. Longitudinal  motion  of  mitral  annulus  can  be  appreciated  visually  
from   parasternal  long-axis  and  apical  four chamber  views, but  TDI  records  and  
demonstrates  the  velocity  of  longitudinal  motion  in  numerical  value. In  the  
normal  heart  with  normal  myocardial  relaxation,  E’  increases  with  exercise  and  
dobutamine.  Velocities  of  longitudinal  mitral  annulus  motion  are  best  obtained  
from  apical  views. Although  various  locations  of  the  mitral  annulus  can  be  
interrogated  with  TDI,  the  two  most  frequently  used  locations  are  septal (or 
medial)  and  lateral  mitral  annulus. Usually, E’  from  the  lateral  annulus is  higher 
(normally >15 cm/sec)  than  the  medial  annulus (normally >10 cm/sec). Late  
diastolic  velocity (Aa or  A’ )  of  the  mitral  anulus at  the  time  of  atrial  
contraction   increases  during  early  diastolic  dysfunction,  as  is  the  case  for  the  
mitral  inflow A wave, but  decreases  as  atrial  function  deteriorates. A’  has  been  
correlated with  left  atrial  function 
MITRAL   ANNULUS    
The mitral valve annulus is a junctional zone that separates and gives 
attachment to muscle of the left atrium and left ventricle and to the mitral valve  
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leaflets.It is not a rigid circumferential fibrous ring, but is pliable 11 and incomplete 
anteriorly.The annulus has two major collagenous structures, the  right and left fibrous 
trigones. The right fibrous  trigone, or central fibrous body, lies in the midline of  the 
heart and represents the confluence of fibrous tissue from the mitral valve,tricuspid 
valve, membranous septum and posterior aspect of the root of the aorta The left 
fibrous trigone is composed of fibrous tissue at the confluence of the left margin of 
the aortic and mitral valves. Between the trigones ventrally, the  anterior leaflet of the 
mitral valve is in direct fibrous continuity with the aortic root. mitral valve annulus is 
elliptical or nearly elliptical and changed shape during the cardiac cycle, being more 
circular in late diastole and flatter in systole. 
LEFT  VENTRICULAR  LONG  AXIS  RESPONSE  TO  DOBUTAMINE                           
The normal left ventricular long axis response to dobutamine infusion proved 
to be very characteristic. Both the  amplitude and peak velocity of motion increased 
with respect to resting values. The increase in shortening velocity with dobutamine 
correlated closely with that in peak aortic acceleration, long recognised as a sensitive 
measure of a positive inotropic stimulus, independent of loading conditions. This 
increase in long axis shortening velocity is thus likely to be another direct effect of the 
positive inotropism of dobutamine. Mitral annular systolic velocity significantly 
increased with only 1 mg/kg/min of dobutamine and further incremental increases 
occurred with each subsequent dose. A linear dose response relation was 
demonstrated within this narrow dosage range. A second effect of dobutamine was 
that systolic long axis motion started sooner after the Q wave and ended  sooner after 
aortic valve closure, so that a consistently greater proportion of its overall shortening 
occurred during ejection indicating increased coordination. In individual control 
subjects, these altered time relations correlated with shortening of QRS duration, 
strongly suggesting that the resulting phase shift in long axis motion was, in part, the 
direct result of more rapid ventricular activation. This concurs with very early work 
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by Wiggers, who suggested that normal left ventricular contraction relies on organized 
activation to develop coordinate tension in both circumferential and longitudinal 
fibers. Overall, therefore, dobutamine had a combined effect in the normal persons, 
both on activation and directly on the myocardium, so that the extent and velocity of 
long axis shortening increased and became more synchronous with ventricular 
ejection. 
Experimental and clinical studies have shown that during acute ischaemia, 
myocardial peak systolic velocity and strain rate were notably reduced or reversed 
within 5 seconds after coronary occlusion and were delayed. In addition, there was 
positive velocity after the end of ejection.6Post-systolic shortening or thickening is a 
sensitive marker of ischaemia and can be easily recognised by high velocity, strain 
rate or strain occurring during the isovolumic relaxation period, often extending into 
the early filling period. Accurate timing of the aortic valve closure is crucial for 
recognition of post-systolic shortening.However, post-systolic shortening is a normal 
finding in healthy subjects occurring in approximately a third of myocardial segments 
and, thus, is not always a marker of disease. Pathologic post-systolic shortening has 
high magnitude with coexisting reduction in systolic strain and strain rate, and its 
peak occurred later than in control subjects. Asynchronous left ventricular long axis 
function is common in patients with chronic stable coronary artery disease. On the left 
side of the heart, both the start and the end of septal long axis shortening are delayed 
with an ECG pattern of left bundle branch block (LBBB) (fig 1), so that both 
isovolumic contraction and isovolumic relaxation become uncoordinated. 
LONG-AXIS   FUNCTION   IN  DILATED  CARDIOMYOPATHY 
Though  numerous  studies  are  available  for  detection  of  coronary  artery  
disease in  patients  with  normal  LV  dimensions, only  limited  data  available  for  
differentiation  of  ischemic  from  nonischemic  DCM  using  long  axis  function  by  
tissue  Doppler.    The dynamics between mitral anulus motion, and, thus, motion of 
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the base of the heart, and filling of the left atrium and ventricle were studied by 
Doppler echocardiography in 12 normal subjects and 28 patients with dilated 
cardiomyopathy by Keren  et al  in 1988.During ventricular systole, the descent of the 
mitral anulus is towards the ventricular apex, the extent of which is 12.8 ± 1.4 mm. 
The end of the descent of the anulus occurs at the cessation of aortic ejection. About 
100 msec later, a rapid recoil of the mitral anulus toward the atrium occurs. This rapid 
recoil contributes to the displacement of blood from the atria into the ventricles in 
early diastole. During atrial contraction, the mitral anulus moves slightly (2.4 ± 0.7 
mm) toward the  atrium and then returns toward its initial position within 120 msec. 
flow. In patients with dilated cardiomyopathy, mitral anulus motion are markedly 
altered in comparison with normal subjects. In all patients, motion of the mitral anulus 
is either reduced or absent.  
  Duncan  and    associates,  in  2003  studied  the  differentiation  of  ischemic 
from  nonischemic   cardiomyopathy  during  dobutamine  stress  by  left  ventricular 
long-axis function  and  compared  with  wall  motion  score  index. Seventy-three 
patients with DCM, 48 with CAD (16 with LBBB), and 25 without CAD (10 with  
LBBB) were studied. Long-axis M-mode, pulsed-wave tissue Doppler echograms 
(lateral, septal, and posterior walls), and WMSI were assessed at rest and at peak 
dobutamine stress. Failure to increase  systolic  amplitude (total amplitude  minus 
postejection shortening)  by  2 mm or early diastolic velocity by 1.1 cm/s was the best 
discriminator for CAD  (systolic amplitude, sensitivity 85%, specificity 86%; 
lengthening velocity, 71% and 94%, respectively; P=NS). Both  had greater predictive 
accuracy than did WMSI (sensitivity 67%, specificity 76%; P<0.001). The predictive 
accuracy  of changes in septal long-axis function was similar to those of average long-
axis function (systolic amplitude  cutoff=1.5 mm, lengthening velocity cutoff=1.5 
cm/s). However in LBBB, systolic amplitude proved to be the only  significant 
discriminator for CAD, with sensitivity and specificity reaching 94% and 100%, 
respectively (P<0.01 versus  early diastolic lengthening velocity). 
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AIM  OF  THE  STUDY 
 
(1) To differentiate  Ischemic  from  Nonischemic  Cardiomyopathy   
using  Tissue  Doppler  Imaging- long  axis  function    during  
dobutamine  stress,  and   
(2) To  compare  long-axis  function  with  wall  motion  score  index  for  
detecting  coronary  artery   disease   in  dilated  cardiomyopathy        
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                                      MATERIALS   AND   METHODS 
Setting   : Department   of   Cardiology, 
     Government   General   Hospital, 
     Chennai-3. 
 
Study   Design  : Single    center,  nonrandomized,  Observational  
          and  Prospective  Study. 
 
Period  of  Study : From  January’  2005  to  December’  2006. 
 
I. Patient   selection 
 
Patients  with  Dilated  Cardiomyopathy  who  were  referred  to  our  
department  for  the  further  evaluation  and  management were  evaluated  
systematically  by    history,  physical  examination,  electrocardiography  and  
echocardiography  along  with  thorough  analysis   of  past  history  and  risk  factors  
for  coronary  artery  disease.       
Inclusion   criteria   
 Patients  were  included  in  this   study  if  they  fulfilled  the   following 
inclusion  criteria : 
(1) Dilated   cardiomyopathy with  LV  end-diastolic  dimension > 5.6 cm 
and  end-systolic  dimension  >4.0 cm. 
(2) Left  Ventricular  ejection  fraction  of  ≤ 40% . 
(3) Patients  must  be  in  NYHA  class  I – III  status,  and  
(4) Age  should  be  ≥  40  years. 
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Both male  and  female  patients are  included. Patients   with  both  regional  
dyssynergy  and  diffuse  hypokinesia  are  included.  Patients  with  LBBB  also  
included  in  our  study. 
Exclusion   criteria 
 Patients  were  excluded  from  the  study  if  they  have  any  of   the   
following. 
 1. Definite  history  or  ECG  evidence  of    prior  MI  
2. Patients  in  heart  failure 
 3. Significant  structural  valvular  heart  diseases 
 4. Atrial  fibrillation 
 5. LV  aneurysm  or  large  tissue  scarring  
6. Patients  with  congenital  heart  disease, prosthetic  heart  valves, 
history  of  myocarditis, anthracycline  or  other  antineoplastic  drug  
exposure,  chronic  renal  failure 
7. Uncontrolled hypertension (systolic BP>200 mmHg,diastolic  BP>110  
mmHg ) 
8. Second  or  third  degree  AV  block 
9. Contraindications  to  dobutamine  infusion 
10. Peripartum  cardiomyopathy 
 
Those  with  anterior  Q  waves  on  surface  electrocardiogram  or   
complaints  of  angina  pectoris  were  included  in  the  study  in  the  absence  of  
clear  history  of   myocardial  infarction. 
 The  study   cohort  comprised  of  32  patients  with   dilated  cardiomyopathy  
of  uncertain  etiology,  21(65.6%)  men  and  11 (34.4%) women  ,  with  ages  
ranging  from  46  to  65  years (mean 56±6) . LBBB  was  present  in  14 (43.8%)   
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patients  and  18(56.2%)  had  normal  activation, i.e  no  LBBB. Twelve  healthy   
persons  without  any  symptoms  and   no  risk  factors  for  coronary  artery  disease  
are  considered  controls. Informed   consent  and  approval  of   Institutional  
Committee  were  obtained.    
II. STUDY   DESIGN 
All  eligible  patients  underwent  Tissue  Doppler  Imaging  at  rest  and  
during  peak  dose  dobutamine  stress.  LV long-axis  M-mode recordings and  
pulsed-wave, tissue Doppler (PWTD) measurements were obtained with the cursor 
positioned at the septal, lateral , and posterior angles of the mitral ring. Total  
amplitude, systolic  amplitude and  postejection  shortening  were  measured  from  
longaxis  M-mode. Both  systolic  and  early  diastolic velocities were  recorded  at 
rest  and  at  the  end of  each  stage of dobutamine  infusion  from  PWTD. 
Measurements from the three longaxis sites were combined  and  average  value   was  
taken  for the  study. Left  ventricle  was  divided  into  16  segments,   according  to  
recommendations  by  American  Society  of  Echocardiography 67. For  each  
segment,  wall  motion(systolic  thickening  and  endocardial  shortening)  was  
qualitatively  analyzed  and  Wall  motion  score  index (WMSI)  was  calculated at  
rest  and  during  peak  dose  dobutamine  stress . Ischemia was defined as worsening 
of wall motion score or failure of a normal segment to develop hyperkinesis during 
dobutamine  stress. 
Coronary angiography was performed via the right femoral approach using the 
Judkins technique. Based   on  coronary  angiographic  finding  patients  were  divided  
into  two  groups: Group I- Patients  with   ≥50%  diameter  stenosis  in   a  major  
epicardial  coronary  artery  or  any  major  branch  vessel  constitute  the  ischemic  
DCM  group,Group II - The  remaining  patients  constitute  the  nonischemic  DCM  
group. Both the  groups  were  further  divided  into  subgroups  based  on  the  ECG  
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as, having  normal  activation (no LBBB-subgroup A)  or   left  bundle  branch  
block(subgroup B).  
Complete  left   bunble  branch  block 
LBBB  was  diagnosed  from  ECG  by  the  following  diagnostic  criteria   
 1. QRS  duration  ≥120  msec 
2. Broad, notched  R  wave  in  lateral  precordial  leads (v 5, v 6)  and  
usually leads   I  and  aVL 
3. Small  or  absent  initial  ‘r’  wave  in  right  precordial  leads  (v 1,v 2) 
followed  by  deep  S wave  
 4. Absent  septal  q  wave  in  left  sided  leads 
 5. Prolonged  intrinsicoid  deflection (≥ 60  msec) in  v 5  and  v 6 
Dobutamine  stress  echocardiography protocol 
Dobutamine stress echocardiography was performed using a standard 
protocol66 in all patients after obtaining informed consent. Cardiovascular drugs were 
stopped 48 h before the study, apart from short-acting nitrates which patients could 
continue until the morning of the investigation. No patient was taking a beta-receptor 
antagonist at the time of the study. Before the infusion was begun, a resting  
echocardiogram was obtained in the left lateral decubitus position using commercially 
available ultrasound equipment (Philips iE 33 system, 5 MHZ probe).Dobutamine 
stress echocardiography was performed with concurrent  ECG, and blood pressure 
monitoring. Patients were studied in the left lateral position during continuous 
intravenous dobutamine infusion. 
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Dobutamine was infused intravenously for 3-minute stages at 5, 10, 20, 30 and 
40 µg/kg/min with  a maximum of 40 µg/kg/min. In patients not  achieving 85% of 
their age-predicted maximal heart rate(defined as 220 beats . mt minus age in years 
for both men and women)  or another end-point  and without symptoms or signs of  
myocardial ischaemia, atropine was administered, starting with 0·25 mg intravenously 
and repeated up to a maximum of 1·0 mg within 4 min with a continuation of the 
dobutamine infusion.  Throughout the dobutamine infusion heart rate and rhythm 
were monitored from a precordial modified lead I or II or III, and blood pressure  was  
recorded every 3 min. Reasons for interruption of the test were: severe angina, 
symptomatic reduction in systolic blood pressure >40 mmHg from baseline, 
hypertension (blood pressure >240/120 mmHg), significant tachyarrhythmias such  as 
atrial fibrillation or ventricular tachycardia,  akinesis or dyskinesis affecting more 
than two segments and any serious side effect regarded as being due to dobutamine. 
Later  side-by-side  comparisons  of  wall  motion  on  the  digitized  quad-screen  
format  was  analyzed. 
LV  dimensions  and  function 
Two-dimensional echocardiography was performed from the parasternal long- 
and short-axis views and apical 4- and 2-chamber views. LV internal  dimension  at  
end diastole was  measured  at  the  onset   of the QRS complex and  systolic internal  
dimension  was  measured  at  the  maximal  excursion  of  the ventricular  septum  
from a parasternal, 2-dimensional  guided M-mode echocardiogram, with the cursor at 
the tips of the mitral valve leaflets. Left  ventricular  ejection  fraction was  calculated  
using  modified  simpson  method 
M-mode  of  mitral  annulus 
LV long-axis  M-mode recordings were obtained with the cursor positioned at 
the septal, lateral , and posterior angles of the mitral ring. M-mode recordings were 
 45
obtained at a paper speed of 100 mm/s.  For  measuring  septal  and  lateral mitral  
annular  motion ,two-dimensional echo guided M-mode recordings were made from 
the apical four-chamber view with the cursor  placed at the septal and lateral sides of 
the mitral annulus. (Figure 1A). Posterior  mitral  annulus  movement  is  recorded  
from  apical  long axis  view. The amplitude of long axis shortening (mm) was 
defined as the maximum excursion of the mitral annulus during systole. Total 
amplitude(TA) was defined as maximum displacement of the ring between the onset 
of   QRS and peak inward  movement  at or  after end of systole. Postejection 
shortening (PES) was measured as the amplitude of shortening after the  systole. 
Systolic amplitude(SA), representing long-axis displacement during ventricular 
ejection, was calculated by subtracting PES from total amplitude(Figure 1B). 
                                                                             
 
 
 
 
 
                                                       
 
 
   
 
 
Figure.1A - M-mode  cursor  
placement  for  measurement  of   
mitral  annular   motion from apical  
four  chamber  view. The  M-mode  
cursor   is  placed  first  at  the  
septal and  then  at  the  lateral  side  
of  the  mitral  annulus   
Figure.1B - An example of  M mode recording of 
the left sided long axis along with an 
electrocardiogram and  phonocardiogram. First 
vertical line represents the onset of the  Q wave and  
the  second  represents  the   first  high frequency 
component of the aortic component of the second 
heart sound. OS, onset of shortening; OL, onset of 
lengthening; A2, aortic component of the second 
heart sound; ECG, electrocardiogram; PCG, 
phonocardiogram 
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Parameters  are  measured  at  rest  and  end  of  each  stage  of  dobutamine  stress.  
Measurements from the three longaxis sites were combined and  average  value   was  
taken  for the  study. 
Pulsed-wave  tissue  Doppler  of   LV  long  axis 
LV long-axis, pulsed-wave, tissue Doppler (PWTD) measurements were 
obtained with the cursor positioned at the lateral, septal, and posterior angles of the 
mitral ring.(Figure 2). A Doppler velocity range of  30 cm/s was selected to display 
systolic and early diastolic velocities. Both  systolic  and  early  diastolic velocities 
were  recorded  at rest  and  at  the  end of  each  stage of dobutamine  infusion .All 
PWTD  recordings were obtained at a paper speed of 100 mm/s. To make data 
comparable with previous studies of wall-motion score index (WMSI), measurements 
from the 3 longaxis sites were combined for PWTD Because LBBB is frequently 
associated with asynchronous septal contraction, septal long-axis values are also 
presented separately. 
   
  A          B 
Figure. 2 – Tissue  Doppler  imaging  of  the  septal (A) and  lateral mitral annulus in a normal Subject.  
In   tissue   Doppler   imaging  of  the  annulus , there  are   three major velocities: Systolic velocity (S’ 
or Sa) ,early diastolic velocity (E’ or Ea) and  late diastolic velocity (A’or Aa).IVC-Isovolumic 
contraction. IVR-Isovolumic relaxation 
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Wall Motion Score Index 
Two dimensional echocardiography was performed from the parasternal long-
and short-axis views and from apical four- and two-chamber views. A full sequence 
of images was recorded at the end of each 3 min stage. Baseline and peak images 
were analysed using the 16-segment model of the left ventricle as recommended by 
the American Society of Echocardiography and WMSI (summation of all segments 
scored divided by the number of segments scored) was calculated67. Segmental wall 
motion was graded 1 to 4 (where 1=normal wall motion at rest and hyperkinesis with 
stress, 2=hypokinesis at rest or segments with normal amplitude at rest but a reduction 
with dobutamine, 3=akinesis, and 4=dyskinesis).Ischemia was defined as worsening 
of wall motion score or failure of a normal segment to develop hyperkinesis during 
dobutamine  stress. Multivessel involvement was defined as a new wall motion 
abnormality in an arterial site distant from the resting wall motion abnormality. 
III. CORONARY   ANGIOGRAM 
Coronary angiography was carried out via the right femoral approach using 
the Judkins technique and  standard projections. Significant CAD was defined as 
≥50% reduction in the absolute lumen diameter of a major epicardial artery or major 
branch vessel(e.g. first diagonal of LAD or obtuse marginal of Cx) estimated by eye. 
The results  were interpreted by observers blinded to the results of stress 
echocardiography 
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IV. STATISTICAL    ANALYSIS. 
Differences between groups are reported as mean±SD. Rest and stress values 
within each study group were compared with a paired Student’s t test. An unpaired 
Student’s t test was used to compare values between groups. In view of multiple t 
tests, a significant difference was set at P<0.01. The incremental value of 
measurements of long-axis function and WMSI were tested with a stepwise logistic 
regression, and a receiver operating characteristic curve was constructed to establish 
the sensitivity and specificity of a range of threshold changes in long-axis and WMSI 
values for angiographic CAD. 
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                                              RESULTS 
Clinical   data 
A  total  of  thirty  two  cases  were  included  in  this  study.  Among  this,  
21(65.6%)  were  males  and  11 (34.4%) were females  ,  with  ages  ranging  from  
46  to  65  years (mean 56±6) . Most  of  the  patients  were  in NYHA  class  II  or  
III. LBBB  was  present  in  14 (43.8%)   patients  and  18(56.2%)  had  normal  
activation, i.e  no  LBBB. Patients  were  divided  into two   groups  based  on  
presence  or  absence  of  significant  coronary  artery  disease  on  coronary  
angiography: Group I- Nonischemic  cardiomyopathy (no  siginificant CAD), Group 
II- Ischemic  cardiomyopathy (significant CAD +)  Baseline  characteristics  of  the  
study  group  is  shown  in  table.1.  
Table  1.  Baseline   characteristics  of   the  study  population 
  
Nonischemic Cardiomyopathy  Ischemic Cardiomyopathy 
                           Controls  NO LBBB      LBBB  NO LBBB    LBBB 
Variable          (n=12)                    (n=10)                    (n=8)    (n=8)   (n=6) p value 
Mean age(±SD)yrs         54±9.1  56±4.4  58±5.2  59±8.0  60±4.4 
    (Range)       (40-62)  (42-55)  (45-66)   (48-65)  (43-68) 0.201 
Gender(M/F)         8/4  6/4  6/2  5/3  4/2 
    Male %               66  60  75  62.5  66.6 0.022 
NYHA  II  n (%)       -  6 (60%)  5 (62.5%)  5 (62.5%)  4(66.7%) 0.842 
NYHA  III  n (%)       -  4 (40%)  3 (37.5%)  3 (37.5%)  2(33.3%) 0.645 
Angina n ( %)                -  4(40)  3(37.5)  5(62.5)  2(33.3) 0.994 
SBP mmHg      130±14  134±10  132±11  128±12  124±10 0.840 
DBP mmHg       76±11  82±8  80±6  78±12  76±8 0.523 
Smoking %                    -  6(60)  4(50)  5(62.5)  4(66.6) 0.416 
Diabetes %                    -  5(50)  3(37.5)  4(50)  2(33.3) 0.014 
Hypertension                 -  4(40)  4(50)  6(75)  3(50) 0.510 
EDD mm                   48±4  70±6  66 ±8  72±6  70±5 0.994 
ESD mm                   34±6  58±5  57±4  60±6  59±8 0.073 
LVEF %                   60±4  31±9  30±11  33±8  28±6 0.842
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Fig. 3 
Each  group  is  further  divided  into  subgroups  based  on  normal  activation  or 
presence  of  LBBB  in  electrocardiography 
 
 
 
 
 
Fig. 4 
 Chest  pain  was  present  in  seven  patients  in  group I ( 4-normal  activation, 
3- LBBB)  and  in  seven  patients  in  group II ( 5-normal  activation, 2-LBBB). In  
both  the  groups  chest  pain  was  more common  in  patients  with  normal  
activation ,  though  it  is  not  significant (table 1 & 2). 
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Table 2 Prevalence of Chest pain 
Group Normal Activation LBBB 
I 
(n = 18) 
4  
(40%) 
3  
(37.5%) 
II 
(n=14) 
5  
(62.5%) 
2 
(33.3%) 
 
Patients  in  both  the  groups  had  LV  end-diastolic  dimension  of  more  
than  6 cm. Patients with both CAD and LBBB had significantly greater LV  end-
diastolic  and  end-systolic  dimensions (Table 1) than did patients with either alone 
(all P<0.01). LV   dysfunction  was  equally  severe  in  both  ischemic  and  
nonischemic  DCM  groups.  
Coronary   angiography  findings 
Fourteen  patients  had  significant  coronary  artery  disease  which  constitute  
ischemic  cardiomyopathy  group (group I).The extent of CAD was not different in  
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subgroups of ischemic cardiomyopathy  group,  although  two  vessel  disease  was 
commoner  in  patients  with  LBBB (Fig 6A & 6B). In  this group  7  patients  had  
three  vessel  disease  and   4  in group A, 3- group B ,most  of  them  had  severe  
involvement  of  LAD. Two  vessel  disease was  present  in  four  patients-2  in  each  
group(2-LAD+RCA,1-LAD+LCX and 1-RCA+LCX).  Three patients   had  single  
vessel  disease-all  LAD  involvement(2- group A, 1-group B) (Table 1). 
 
 
 
 
 
 
 
      Fig.6A       Fig. 6B 
In  nonischemic  cardiomyopathy  group,  12  patients  had  normal  coronary  
anatomy  and  6  had  insignificant  lesions of  less  than 50% luminal  diameter. 
Dobutamine  stress  end-point 
No  differences  in  mean  infused  dose  of  dobutamine,  achievement  of  
maximal  dose  of  dobutamine  and  of  85%  of  maximal  predicted  heart  rate. Also  
no  difference  was  seen  in  the  peak  dose dobutamine  and  blood  pressure. Eight   
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Table  3.  Clinical   details   of  study   population 
          Nonischemic Cardiomyopathy        Ischemic Cardiomyopathy 
                  
                Controls         No  LBBB            LBBB             No  LBBB         LBBB 
Variable                  (n=12)             (n=10)                   (n=8)               (n=8)          (n=6) 
 
EDD mm       48±4  64±6  66 ±6  66±8           70±5*† 
ESD mm       34±6  57±5  57±4  60±6         62±8*†
  
Three  vessel  disease         0  0  0  4  3 
 
Two vessel  disease                  0  0  0  2 
 2 
 
Single  vessel  disease         0  0  0  2  1 
 
Stress  echo  endpoint 
 
     Dobutamine  dose,      30±5  30±5  35±5  30±5            35±5 
         (mcg/kg/mt) 
     Peak  HR /mt       122±10 116±18  110±14  121±11           120±16 
 
     Chest  pain,n         0  1  1  3  2  
      
     Breathlessness,n                0  0  1  2 
 2 
 
     Ventricular ectopics        0  2  2  2  1 
 
     Hypotension         0  0  1  0  2 
 
     VT          0  0  0  0  0
          
Values are mean±SD. NA indicates normal activation; EDD, end-diastolic dimension; and ESD, end-systolic 
dimension.*P<0.001, ischemic cardiomyopathy (LBBB) vs nonischemic cardiomyopathy (LBBB).†P<0.01, ischemic 
cardiomyopathy: LBBB vs NA. 
 
patients  required atropine  for  achieving  target  heart  rate (five  in  group II and  
three  in   group I).5 patients with ischemic  cardiomyopathy developed chest  pain  
during stress, but  only  in  two  patients in  nonischemic  group. None  of the  patients  
had  VT  in  either  group.(Table 3). Hypotension  developed  in   three   patients (one 
in group I, two  in  group II).    
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Changes   in   Average   Long-Axis  Function  With  Stress  
Table  4.  Changes  in  Average  Long  Axis  Function  With  Stress 
 
Nonischemic Cardiomyopathy        Ischemic Cardiomyopathy 
 
   Controls  No  LBBB    LBBB  No  LBBB LBBB 
Variable      (n=12)                  (n=10)                  (n=8)    (n=8)   (n=6) 
 
Rest 
    TA, mm 12.4±1.3  10.8±1.8 * 7.2±1.2 †† 8.8±2.4 ‡‡ 6.0±1.6 § 
 
    SA, mm 12.4±1.3  10.8±1.8 * 6.3±0.9 †† 7.8±1.9 ‡‡ 5.3±1.8 § § 
     
    PES, mm    0±0     0±0  1.0±0.7 †† 0.6±0.5 ‡‡ 1.0±0.6 
 
    SV,  cm/sec 7.6±1.6  3.6±1.5 * * 3.4±1.2  3.9±1.3  2.4±1.2 § 
 
    EDV, cm/sec 7.2±1.8  5.2±1.0 *  5.0±1.4  3.9±1.2 ‡‡ 2.4±1.0 § 
 
    WMSI      -  2.4±0.18  2.08±0.36† 2.2±0.22 ‡‡ 2.36±0.2 § 
 
Response  to  stress 
    ∆  TA, mm  +3.8±0.7¶¶ +2.9±1.5 ¶¶ +2.0±0.9 ¶¶ +1.4±0.9 ¶¶ +1.3±1.1 ¶¶ 
 
    ∆  SA, mm +3.8±0.7 ¶¶ +2.9±1.5 ¶¶ +2.8±1.0 ¶¶ +0.6±1.2  0.5±1.5 
 
    ∆  PES, mm    0±0     0±0  −0.9±0.6 ¶ +0.8±0.6 ¶¶ +0.8±0.8 ¶¶ 
 
    ∆  SV, cm/s +4.2±1.6 ¶¶ +3.6±2.2 ¶¶ +3.6±2.3 ¶¶ +1.2±0.8 ¶¶ +1.1±1.0 ¶ 
 
    ∆ EDV, cm/s +2.4±0.9 ¶¶ +4.5±2.1 ¶¶ +2.9±1.9 ¶¶ +0.5±1.6  +0.2±1.8 
 
     WMSI      -  -0.36±0.26 ¶¶ +0.06±0.28 +0.07±0.28 +0.05±0.25 
 
Values are mean±SD. NA indicates normal activation; TA, total amplitude; SA, systolic amplitude; SV, systolic velocity; and 
EDV, early diastolic velocity. *P<0.01, **P<0.001, nonischemic cardiomyopathy (NA) vs controls at rest. †P<0.01, 
††P<0.001, nonischemic cardiomyopathy: LBBB vs NA at rest. ‡P<0.01, ‡‡P<0.001, ischemic cardiomyopathy (NA) vs 
nonischemic cardiomyopathy (NA) at rest. §P_0.01, §§P_0.001, ischemic cardiomyopathy (LBBB) vs ischemic cardiomyopathy 
(NA) at rest. ¶P<0.01, ¶¶P<0.001, stress vs rest within group. 
In nonischemic cardiomyopathy (Table 4), the average longaxis response to 
stress was similar to that of  control subjects, irrespective of LBBB. Total amplitude, 
systolic amplitude, systolic velocity, and early diastolic velocity all increased           
(all P<0.001)  during  peak  dose  dobutamine; PES did not appear in any patient; and 
in those with LBBB, PES amplitude fell (P<0.01).  
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In ischemic cardiomyopathy (Table 5), systolic amplitude and early diastolic 
velocity failed to increase, and PES was exaggerated (P<0.001) in  patients  with  
normal  activation. Systolic velocity did increase, but by less than in nonischemic 
cardiomyopathy (P<0.01). With LBBB, systolic amplitude, systolic velocity, and 
early diastolic velocity increased even less with stress, whereas PES was greater (all 
P<0.01). 
Changes in Septal Long-Axis Function With Stress 
In nonischemic cardiomyopathy group,the septal long-axis response to stress  
Table. 5.  Septal  Long-axis  Function 
 
Nonischemic Cardiomyopathy  Ischemic Cardiomyopathy 
  
    Controls  No  LBBB      LBBB  No  LBBB    LBBB 
Variable      (n=12)                  (n=10)                     (n=8)   (n=8)     (n=6) 
 
Rest 
    TA, mm 13.0±2.1  11.3±2.8  6.4±1.5†  7.3±2.9‡‡ 4.6±2.2§ 
 
    SA, mm 13.0±2.1  11.3±2.8  4.4±1.6†  6.4±2.7‡‡ 3.4±2.4§ 
     
    PES, mm    0±0     0±0  1.7±0.9†  1.0±1.1‡  1.2±1.2 
 
    SV,  cm/sec 6.8±1.5  3.4±1.0*  3.4±0.9  2.7±0.6  1.1±1.3§ 
 
    EDV, cm/sec 5.6±1.4  5.2±1.8  4.6±2.0  3.3±1.6‡‡ 0.8±1.7§ 
 
Response  to  stress 
    ∆  TA, mm  +3.6±2.4¶¶ +3.2±1.2¶¶ +1.2±0.5¶¶ +1.0±1.6¶ +1.3±1.5¶ 
    ∆  SA, mm +3.4±2.3¶¶ +3.2±1.0¶¶ +2.6±0.9¶¶ -0.4±1.7  +0.4±0.1 
 
    ∆  PES, mm    0±0     0±0  −1.4±1.0¶¶ +1.3±1.2¶¶ +0.9±1.2¶ 
    ∆  SV, cm/s +4.2±1.8¶¶ +3.6±1.6¶¶ +3.1±2.2¶ +1.7±1.9¶ +1.4±1.6 
 
    ∆ EDV, cm/s +2.7±1.67¶¶ +3.8±1.9¶¶ +2.4_1.7 ¶ +1.3±1.5¶ +0.5±2.4  
 
Values are mean± SD. NA indicates normal activation; TA, total amplitude; SA, systolic amplitude; SV, systolic velocity; and EDV, early diastolic velocity. 
*P<0.001, nonischemic cardiomyopathy (NA) vs controls at rest. †P<0.001, nonischemic cardiomyopathy: LBBB vs NA at rest. ‡P_0.01, ‡‡P_0.001, 
ischemic cardiomyopathy (NA) vs nonischemic cardiomyopathy (NA) at  rest..§P<0.00l, ischemic cardiomyopathy (LBBB) vs ischemic cardiomyopathy (NA) 
at rest. ¶P<0.01, ¶¶P<0.001, stress vs rest within group. 
was similar to that in control subjects  in   patients  with  LBBB (Table 4),. By 
contrast, septal systolic  amplitude and velocities failed to change in ischemic 
cardiomyopathy and LBBB (Table 5), but   PES amplitude  was  increased (P<0.01). 
Dobutamine  stress  echocardiography  and  Wall   Motion  Score  Index (WMSI) 
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At  rest : Global  LV  function  was  severely  depressed  in  both  ischemic 
(ejection  fraction, 0.31±0.9 and  0.30±11; WMSI, 2.4±0.18 and 2.08±0.36 in  
subgroup A and B respectively, p=NS) and  nonischemic  groups (ejection  fraction, 
0.33±0.8 and  0.28±0.6; WMSI, 2.2±0.22 and 2.36±0.2 in  subgroup A and B 
respectively, p=NS). There  was  a  trend  toward  more  akinetic  segments  per  
patient  with  ischemic  DCM   than  per  patient  with  nonischemic  segment (p=NS). 
Although  LV  hypocontractility  tended  to  be  more   homogenously  distributed  in  
patients  with  nonischemic  DCM, large  overlaps  of  individual  data  were  
observed  at  baseline   between   the  two  groups. In  both  the  groups  higher   
WMSI  was  found  to  be  correlated  with  presence of   three   vessel  disease.     
Low  dose  dobutamine : At  low  dose  dobutamine,  contractility  improved  
and    WMSI  decreased  in  both  groups. With  respect  to  baseline, there  was  an  
increase  in  normal  segments  and  a  decrease  in  akinetic  segments, either  per  
ischemic  or  nonischemic  DCM  patient. However,  with  respect  to  baseline,  
significant  decrease  in   severely  hypokinetic  segments  per  patient  is  seen  only  
in  nonischemic  DCM  group. 
Peak   dose  dobutamine  :  Global WMSI fell further  with stress in 
nonischemic cardiomyopathy and normal activation (group IA), i.e significant of 
number of segments  showed improved contractility  with   PD dobutamine 
(P<0.001).  But WMSI  increased  in all  other  group, particularly  so in patients  with  
ischemic  cardiomyopathy  and  normal  activation. Biphasic  response  was  noted  in  
11  of  14  patients   with  ischemic  cardiomyopathy  and  2  of  18  patients  with  
nonischemic  cardiomyopathy. The  higher  increase  in  WMSI  in  ischemic  group  
is  found  in  patients  with  extensive  involvement  of  coronary  arteries (three  and  
two  vessel  disease) .  
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Fig.7 
With  respect  to  baseline,  the  number  of  segments showing  improved  
contractility  was  increased  in  both  groups  during  low  dose  dobutamine.  During   
peak  dose  dobutamine    further  increase  in  contractility  was   noted  only  in  
nonischemic  group  but  decreased  in  ischemic  group i.e. biphasic  response   
(Figure 7). 
  
Prediction of CAD From Changes in Average Long-Axis and WMSI Values 
With Stress 
Stress-induced changes in average long-axis amplitude, shortening, and early 
diastolic lengthening velocities and in WMSI were all univariate predictors of CAD  
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Table 6. Predictors of CAD 
 
Variable         t      AUC (CI)    Cutoff       X2          P    Sensitivity, %  Specificity,% 
 
∆ Average SA, mm       +4.0     0.90 (0.84–0.96)     +1.96     16.6   <0.001           86       90 
∆ Average SV, cm/s      +3.4    0.76 (0.65–0.90)*     +2.67    11.4   <0.001           90       70 
∆ Average EDV, cm/s  +3.3    0.85 (0.70–0.92)     +1.04    10.0   <0.001           78                    94 
∆ Average TA, mm        2.8    0.66 (0.60–0.82)**  +2.0      8.8      0.003           70       60 
∆  WMSI       -2.5    0.66 (0.58–0.80)**   -0.13      6.8     0.006           62         88 
Septal   predictors   of   CAD 
All patients  (n=36)  
    ∆ Septal SA, mm     +3.6   0.90 (0.81–0.96)     +1.3     14.8     <0.001               89      100 
    ∆ Septal SV, cm/s   +2.6   0.72 (0.57–0.85)†     +1.8        7.9       <0.01  75        76 
    ∆ Septal EDV, cm/s +2.6   0.80 (0.66–0.88)     +1.5        8.0      <0.01               71        94 
    ∆ Septal TA, mm     +3.1   0.74 (0.62–0.83)†       +0       9.6      <0.01               40        98 
LBBB (n=14) 
  ∆ Septal SA, mm       +2.1        0.89 (0.82–0.96)     +1.3       6.0      <0.01               94       100         
  ∆ Septal SV, cm/s     +1.8    0.64 (0.40–0.87)‡     +1.8       2.6        NS                76         68 
   ∆ Septal EDV, cm/s  +1.5    0.73 (0.50–0.82)‡     +1.5       2.0         NS                67         78 
   ∆ Septal TA, mm       +0.6    0.60 (0.40–0.80)‡       +0       0.6         NS                42         97 
 
t indicates coefficient/SE; AUC, area under curve; CI, 95% confidence interval; SA, systolic amplitude; SV, systolic velocity; EDV, early diastolic velocity; and 
TA, total amplitude. *P<0.01, **P<0.001, vs AUC for average SA. †P<0.01, vs AUC for septal SA (all patients).‡P<0.01, vs AUC for septal SA (LBBB alone). 
 
(Table 6). The best discriminators, however, were changes in systolic amplitude and 
early diastolic lengthening velocity (both P<0.001). An increment of 2 mm in systolic 
amplitude correctly identified 12 of  14 patients with CAD and 16 of  18 patients 
without CAD (sensitivity 86%, specificity 89%), whereas an increment of 1.0 cm/s in 
early diastolic lengthening velocity identified 11of 14 patients with CAD and 17 of 18 
patients without CAD (sensitivity 78%, specificity 94%). The predictive accuracy of 
both systolic amplitude and early diastolic velocity for detecting CAD was 
significantly greater than that  of changes in WMSI (P<0.001). In the LBBB group, 
the same cutoff criteria gave a sensitivity and specificity of 88% and 89% (systolic 
amplitude), 70% and 88% (early diastolic lengthening velocity; difference NS), and 
62% and 88% for WMSI (P<0.001 versus systolic amplitude), respectively. 
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Prediction  of  CAD  From  Septal  Long-Axis  Values 
Changes in septal systolic amplitude in the study population had a predictive accuracy 
similar to that of average long-axis function, with systolic amplitude (cutoff=1.5 mm) 
and early diastolic lengthening velocity (cutoff=1.5 cm/s) being the best 
discriminators (Table 5). However, in the LBBB group, systolic amplitude proved to 
be the only significant discriminator for CAD (cutoff=1.5 mm), with sensitivity and 
specificity reaching 94% and 100%, respectively (P<0.01 versus early diastolic 
lengthening velocity). 
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DISCUSSION 
The underlying diagnosis in patients presenting with left ventricular dilatation 
and impaired systolic function, and no evidence of a known cardiac or systemic 
disease, sometimes remains clinically undetermined. Individuals who never 
experienced angina or myocardial infarction may have unrecognized extensive 
coronary artery obstruction, whereas patients with angina may lack coronary 
stenoses  46. Accurate distinction of ischaemic from non-ischaemic cardiomyopathy is 
fundamentally achieved by coronary angiography, which also delineates the coronary 
anatomy before considered revascularization. Several techniques have been utilized 
for non-invasive differentiation. Up to 60% of patients with severe cardiomyopathy 
have left bundle branch block (LBBB) , which can mask the evidence of previous 
infarction and make the interpretation of  electrocardiographic changes with exercise 
testing (without imaging) impossible 7  Radioisotope perfusion imaging and stress 
echocardiography have been acceptable and feasible methods 15-17,51. However, 
overlaps and dissimilar findings have been described especially in low ejection 
fractions and severe wall motion  abnormalities. Positron emission tomography is 
extremely useful in assessing myocardial viability and also precisely differentiates 
between ischaemic and dilated cardiomyopathy 19. However, it is problematic in 
diabetic patients and its application is limited because of unavailability and high cost. 
Longitudinal myocardial fibers are predominately subendocardial  and are sensitive to 
ischemia and abnormal activation.   Furthermore, stress-induced changes in long-axis  
function can be measured objectively. Comparing   long-axis behavior at rest and 
during stress  in ischemic and nonischemic cardiomyopathy   provide define criteria 
for differentiating  between them. 
 61
Stress-Induced Changes  in  long  axis  function 
The normal left ventricular long axis response to dobutamine infusion proved 
to be very characteristic. Both the amplitude and peak velocity of motion increased 
with respect to resting  values. Hoglund et al. in 1988, first documented changes in the 
left ventricular long axis during systole in healthy volunteers and suggested these 
could be used to assess ventricular function in man. Simonson and Schiller 39 showed 
that a reduction in long axis function, called descent of the base in their study, 
correlated well with impaired left ventricular ejection fraction in a large group of 
patients including those with coronary artery disease. Only  limited  data  is  available  
regarding  use  of  long  axis  function  in  differentiation  of  cardiomyopathies. 
Mishra  et al 38  in  2002  compared long-axis function and wall motion analysis for 
the detection of significant coronary artery stenoses in patients with single and 
multivessel disease. A blunted increase in mean long-axis shortening of < 2.5 mm was 
the best discriminator for coronary artery disease (sensitivity 85%, specificity 81%). 
Using this threshold, long axis function had a sensitivity of 88% and specificity 89% 
for the detection of coronary artery disease in patients with normal resting wall 
motion while wall motion abnormality analysis had a sensitivity 73% and specificity 
94%. But  most  of  the  patients  in  his  study  had normal  LV  dimensions. 
Duncan et  al, in  2003  first  used  long axis  parameters  to  differentiate  
ischemic  and  nonischemic  cardiomyopathy 45. He  suggested failure to increase 
systolic amplitude by 2 mm or early diastolic velocity by 1.1 cm/s was the best 
discriminator for CAD (systolic amplitude, sensitivity 85%, specificity 86%; 
lengthening velocity, 71% and 94%, respectively; P=NS). It had greater predictive 
accuracy than did WMSI (sensitivity 67%, specificity 76%; P<0.001). The predictive 
accuracy of changes in septal long-axis function was similar to those of average long-
axis function (systolic amplitude cutoff =1.5 mm, lengthening velocity cutoff =1.5 
cm/s). However in LBBB, systolic amplitude proved to be the only significant 
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discriminator for CAD, with sensitivity and specificity reaching 94% and 100%, 
respectively (P<0.01 versus early diastolic lengthening velocity). 
In our  study  Stress-induced  changes  in  total long-axis amplitude, systolic 
long-axis velocities, and WMSI all distinguished ischemic from nonischemic 
cardiomyopathy 
Average  systolic and  total  amplitude,  and  lengthening  velocities 
 In  our  study  average  systolic  amplitude  cut-off   of  1.96 mm(2 mm)  
differentiated  ischemic  and  nonischemic  cardiomyopathy  with  sensitivity  of  86%  
and  specificity  of  90%  which  comparable  with  Duncan’s  study. Failure  to   
increase  average  total  amplitude  of  2.0  mm  had  lower  sensitivity  and  
specificity (70%  and  60%  respectively).Average  end-diastolic  velocity  had  less 
sensitivity  and  more  specificity  than  average   systolic  velocity. Blunted  increase  
in  EDV (cut off=1.04)  had  sensitivity  of  78%  and  specificity  of  94%. 
Septal  predictors  of  coronary  artery  disease   
   Because  LBBB  is  frequently  associated  with  asynchronous  septal 
contraction,  septal  long-axis values are also presented separately. In  patients  with   
normal  activation sepatal  systolic  amplitude, total  amplitude, end-diastolic  and  
systolic  velocities  all distinguished  ischemic  from  nonischemic  cardiomyopathy. 
But  in  patients  with  LBBB,  failure to increase septal systolic amplitude by <1.3 
mm with stress was the only discriminator for CAD and was highly sensitive and 
specific ( 94%  sensitivity  and  100%  specific). This  is  also  comparable  with  
Duncan’s  observation, but  cut-off  value  in  his  study  is  higher (1.5 mm). This  
may  be  partially  explained  by  the relatively  more  severe  LV  dysfunction  in  our  
patients.    
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 On   summary,  though Stress-induced changes in total long-axis amplitude, 
systolic long-axis velocities, and WMSI all distinguished ischemic from nonischemic 
cardiomyopathy,the best overall predictors of CAD, however, were changes in long-
axis systolic amplitude and early diastolic lengthening velocity. Failure to increase 
systolic amplitude by 2 mm or early diastolic lengthening velocity by 1.0 cm/s with 
stress, even  when LBBB was present, had a greater predictive accuracy than did 
changes in WMSI. In LBBB, failure to increase septal systolic amplitude by >1.3 mm 
with stress was the only discriminator for CAD and was highly sensitive and specific. 
Wall   motion  score  index 
 The sensitivity  of   WMSI  in  previous  studies  for  detecting  CAD  in  
dilated cardiomyopathy ranged between 26% and 100%. In  Mishra’s  observation  
wall motion abnormality analysis had a sensitivity 73% and specificity 94% 38. Sharp 
et al  demonstrated  that  the  use   of  change  in  global  wall  motion  score  index  
from  low  to  peak  dose   dobutamine  resulted  in  sensitivity  of  83%  and  
specificity  of  71%  for  detection   of  coronary  artery disease. In  our  study  WMSI  
had  lower  sensitivity (62%)  and  higher  specificity (88%)   compared  with  
Duncan’s study. The  sensitivity  and  specificity  of  WMSI  in  detecting  CAD  is  
lower  than  long axis  function. 
Mechanisms 
 The greater sensitivity of changes in long-axis function over  WMSI might 
have several explanations. (1) The mitral ring gives rise to a strong echo, even when 
image quality is suboptimal,so that systolic amplitude and PWTD signals are simple 
to quantify even in patients with LBBB, thereby providing objective and reproducible 
measurements. In contrast, WMS analysis remains semiquantitative and dependent on 
operator experience. (2) A further advantage of long-axis assessment is that 
incoordinate long-axis shortening after aortic valve closure can be distinguished from 
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that during ejection, an assessment that is not possible with the repetition rate of  2-
dimensional imaging.(3) Finally, the contrasting effects of stress in LBBB with or 
without ischemia meant that septal long-axis measurements performed particularly 
well in this group. This probably reflected their direct 
Study  Limitations 
This is  a  single  centre  study  with  small  number  of  patients. As in 
previous studies, patients with significant ventricular arrhythmias and atrial 
fibrillation which  constitute  important  in both  groups  of  cardiomyopathies, were 
not included. Strain-rate imaging might constitute another useful method for 
analyzing regional LV function in this setting, but this technique is not yet widely 
available, and its predictive accuracy in patients with LBBB has not been studied. It  
has   been  reported  that  patients  with  ischemic DCM  more  commonly  have  
preserved  right  ventricular  function  and  size  compared  with  those  with  
nonischemic  DCM . In  our  study, the  two  groups  of  patients  with  did  not  have  
significantly  different  right  ventricular  size  on  echocardiogram.  However,  the   
response  of  the  right  ventricle  to  dobutamine  was  not  analyzed.     
Differentiating  of  ischemic  and  nonischemic  cardiomyopathy  solely  on  
the  basis  of  coronary  angiography  is  imprecise  because  more  than  one  process  
may  be  present  simultaneously, i.e  the  association  of  DCM  and  coronary  artery  
disease  does   not  imply  in  all  patients (especially in single  vessel  disease) that  
the DCM  is  ischemic  in  origin.  Moreover,  angiography  does  not  provide a  
physiological  assessment  of  severity  of  coronary  artery  disease. 
Practical   implications 
 Differentiation  of  ischemic  from  idiopathic  dilated  cardiomyopathy 
noninvasively  is    important  in  the  prognostication . It   reduce  the  need  for  
invasive  procedures   and  their  attendant  complications. Identification  of  ischemic  
cardiomyopathy  by  noninvasive  methods  is  particularly  important  in  planning   
further  definitive  management  in  such  patients. 
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CONCLUSIONS 
 
 
  
(1) Tissue  Doppler  Imaging  during  dobutamine  stress  is  a  simple,  
and effective   non-invasive   modality  in  differentiating  ischemic  
from nonischemic  dilated  cardiomyopathy  
(2) Blunted response to dobutamine identifies  ischemic  cardiomyopathy 
(3) Tissue Doppler  Imaging  was   especially  useful  in  patients  with  
left bundle  branch  block  and  dilated  cardiomyopathy 
(4) Tissue Doppler  Imaging   findings  correlate  well  with  coronary        
 angiogram 
 
 
 
 
 
 
 
Figure  8.  Top, Long-axis excursion normally increases with stress, and PES does not appear. Middle, In 
nonischemic cardiomyopathy and LBBB, amplitude is reduced at rest but increases with stress.Bottom, In 
ischemic cardiomyopathy and LBBB, amplitude is reduced and PES is present at rest, and neither changes with 
stress. PCG indicates phonocardiogram;A2, aortic valve closure; and q, Q wave of the ECG. 
 
 
 
 
 
 
 
 
 
Figure - 9A  ECG  of  a  nonischemic  DCM patient  Mr. K  shows  LBBB 
 
 
 
 
 
Figure - 9B. Pulsed Wave Tissue  Doppler  of  mitral annulus  of  the  same  patient Mr. K  at  rest 
shows  decrease  in  systolic  and   early  diastolic   velocity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure - 9C Pulsed  Wave Tissue  Doppler  of  mitral annulus of  Mr. K during    Dobutamine shows 
normal  increase  in  systolic  and   early  diastolic   velocity 
 
 
 
 
Figure - 9D. M-mode of mitral annulus Mr. K at rest shows decrease in systolic amplitude 
 
 
 
 
 
 
 
 
Figure -9E M-mode of mitral annulus Mr. K at rest shows decrease in systolic amplitude 
 
 
 
 
 
 
 
 
Figure -9F M-mode of mital annulus of  Mr. K during  peak dose dobutamine  shows normal increase   
in systolic amplitude 
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Figure - 9G. Coronary  angiogram  Mr. K  shows  normal  epicardial  coronary  arteries 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure - 10A. ECG  of  an  Ischemic  DCM   patient  Mr. R  shows  LBBB 
 
 
 
 
 
 
 
Figure – 10B. Pulsed Wave Tissue  Doppler  of  mitral annulus  of  the  same  patient Mr. R  at  rest 
shows  decrease  in  systolic  and   early  diastolic   velocity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure – 10C. Pulsed Wave Tissue  Doppler  of  mitral annulus  of   Mr. R  during  dobutamine Stress    
shows  blunted  increase   in  systolic  and   early  diastolic   velocity 
 
 
 
 
 
Figure - 10D. M-mode of mitral annulus Mr. R at rest shows decrease in systolic movement towards  
ventricle 
 
 
 
 
 
 
 
 
 
Figure - 10E. M-mode of mitral annulus Mr. R at  peak   dobutamine shows blunted  increase  in 
systolic excursion  of  annulus 
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Figure - 10F. Coronary  angiogram  Mr. R  shows  three  vessel  disease 
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PROFORMA 
 
UTILITY  VALUE  OF  TISSUE  DOPPLER  IMAGING    DURING  
DOBUTAMINE  STRESS  IN  DIFFERENTIATING  ISCHEMIC  FROM  
NONISCHEMIC  DILATED  CARDIOMYOPATHY 
 
 
Patient   name  :     Address : 
Age   :      
Sex   :     MRD NO. : 
Date   :     CD  NO. : 
 
HISTORY 
Chest  pain :     Dyspnea : 
Palpitation :     Syncope : 
Pedal  edema :     Cough  : 
H/O Prior MI :     Rx details : 
RISK  FACTOR  ASSESSMENT 
Hypertension :     Diabetes : 
Dyslipidemia :     Obesity : 
Smoking :     Family CAD : 
EXAMINATION 
Pulse rate :     Blood pressure: 
JVP  : 
ELECTROCARDIGRAM 
 
CHEST  X  RAY 
 
ECHOCARDIOGRAPHY 
 
Baseline  Echocardiogram 
 
  Two  dimensional : 
 
  M- mode  :LVIDd-   LVIDs -  
   
Color  flow  : 
 
  Ejection  fraction : 
 
Tissue  Doppler  at  rest 
         Septal   lateral posterior 
 
1.Total  amplitude, mm  - 
2.PES,  mm    - 
3.Systolic  amplitude, mm  - 
4.Systolic  velocity, cm/sec  - 
5.Early  diastolic  velocity, cm/sec - 
 
Dobutamine  stress  echocardiography(DSE) 
 Maximum  dose required -   Total  dose  infused -
 Atropine  requirement  -   Peak  heart  rate / mt - 
 Chest  pain   -   Hypotension  - 
 Ventricular ectopics  -   V T   - 
 Death    - 
Tissue  Doppler  during  DSE 
         Septal   lateral posterior 
1.Total  amplitude, mm  - 
2.PES,  mm    - 
3.Systolic  amplitude, mm  - 
4.Systolic  velocity, cm/sec  - 
5.Early  diastolic  velocity, cm/sec - 
  
LV  contractility and  16-segments wall motion  score index 
 
 1.At  rest   
 
 2.During  low  dose  dobutamine 
 
 3.During  peak  dose  dobutamine 
CORONARY  ANGIOGRAM     Date  : 
         CD NO : 
 
 LMCA    - 
  
LAD    - 
 
  septals  - 
 
  diagonals - 
 
LCX    - 
 
RCA    - 
 
Collaterals   - 
 
 
Final  Impression 
 
DISCUSSION 
 
 
